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ABSTRACT 
Vitamin B12 is the most complex vitamin in existence and one of the most 
complex non-polymeric molecules occurring in nature. It is predominantly 
present in animal-derived products, which places vegetarians and people with 
limited access to animal-derived foods at risk for developing vitamin B12 
deficiency. With the current trend of limiting the consumption of foods of 
animal origin, the deficiency may also affect other populations. 
In situ fortification of foods through microbial fermentation with food-
grade bacteria is a viable method for the introduction of vitamin B12 into 
foods, if the microorganism is capable of synthesising the active vitamin form. 
Here, the capability of Propionibacterium freudenreichii to produce active 
vitamin B12 was explored with the use of a combination of microbiological and 
molecular approaches.  
First, the activity of the heterogolously expressed and purified enzyme 
BluB/CobT2 was investigated. The results showed that the novel fusion 
enzyme was responsible for biosynthesis of 5,6-dimethylbenzimidazole 
(DMBI) base and its activation for attachment as the lower ligand of vitamin 
B12. The enzyme’s inability to activate adenine, the lower ligand of 
pseudovitamin B12, revealed a mechanism favouring production of active 
vitamin B12 in P. freudenreichii. The in vivo study showed that formation of 
DMBI is oxygen dependent as no vitamin B12 was produced under strictly 
anaerobic atmosphere. Exogenous DMBI was incorporated into the vitamin 
molecule under both microaerobic and anaerobic conditions, with a clear 
preference over incorporation of adenine. 
 In the following study, the capability of 27 P. freudenreichii and 3 
Acidibacterium acidipropionici strains to produce active vitamin B12 was 
examined by UHPLC. The yields obtained from growth in whey-based medium 
enriched in cobalt and supplemented with either DMBI, with the precursors 
of DMBI- riboflavin and nicotinamide, or without supplementation. A. 
acidipropionici strains required supplementation of DMBI to produce small 
amounts of active vitamin B12 (<0.2 μg/mL), while all of the P. freudenreichii 
strains were able to produce active vitamin B12 in all conditions tested. The 
yields of active vitamin B12 produced by P. freudenreichii and responses to 
supplementation were strain dependent and ranged from 0.2 to 5.3 μg/mL.  
 Subsequently, the active vitamin B12 production by the strain P. 
freudenreichii 2067 without addition of cobalt or DMBI was tested. The 
experiments were performed in a medium mimicking cheese environment as 
well as in the whey-based medium. The production of other key metabolites 
was examined by HPLC, while the global protein production was compared by 
gel-based proteomics. The results showed that regardless of different effects 
of the media on the metabolic state of the cells, which was reflected by distinct 
metabolite and protein production patterns, P. freudenreichii produced 
nutritionally relevant levels of active vitamin B12. 
 Finally, whole genome sequencing was employed to better characterise the 
species through a comparative genomics study. The use of PacBio sequencing 
platform, a PCR-free method producing long reads, resulted in discovery of 
additional circular elements: two novel, putative conjugative plasmids and 
three active, lysogenic bacteriophages. The long reads also permitted 
characterisation and classification of two distinct types of CRISPR-Cas 
systems. In addition, the use of PacBio sequencing platform allowed for 
identification of DNA modifications, which led to characterisation of 
Restriction-Modification systems together with their recognition motifs, many 
of which were reported for the first time. Genome mining suggested surface 
piliation in the strain P. freudenreichii JS18, which was confirmed by 
transmission electron microscopy and assessment of specific mucus binding. 
Taken together, the results reported in this work support the role of P. 
freudenreichii as the only known candidate for in situ fortification of foods in 
vitamin B12. The species meets the requirements of having the food-grade 
status and showing the capability to produce appreciable amounts of active 
vitamin B12 without the need for the addition of supplements that are 
forbidden in food production. The whole genome sequencing, besides 
contributing to a better understanding of this bacterium, will allow for the 
development of novel applications and facilitate further studies. 
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 INTRODUCTION 
Propionibacterium freudenreichii is an Actinobacterium that belongs to 
the order Propionibacteriales, family Propionibacteriaceae and genus 
Propionibacterium. The name “Propionibacterium” was first suggested in 
1909 by Orla-Jensen, based on the large amounts of propionic acid produced 
during fermentation by these bacteria (Vorobjeva, 1999a). Over the years, the 
genus was reclassified multiple times, and recently, owing to the amassing 
genomic data, it was divided into four genera: Propionibacterium, 
Acidipropionibacterium, Cutibacterium and Pseudopropionibacterium. 
Genus Propionibacterium currently includes four species: Propionibacterium 
freudenreichii (type species), Propionibacterium cyclohexanicum, 
Propionibacterium acidifaciens and Propionibacterium australiense. The 
characteristics of the genus include a high GC% content, varying from 64 to 
70%, and the presence of meso-2,6-diaminopimelic acid as the diagnostic 
amino acid in the peptidoglycan (Scholz and Killian, 2016). 
Historically, and per the latest edition of Bergey’s Manual of Systematic 
Bacteriology (Patrick and McDowell, 2012), the species P. freudenreichii is 
divided into subspecies freudenreichii and shermanii. This subdivision is 
based on two phenotypic characteristics: the ability to reduce nitrate and the 
ability to utilise lactose, with the former positive and the latter negative for the 
subspecies freudenreichii and vice versa for the subspecies shermanii. 
However, after genetic data became available, the subdivision was repeatedly 
challenged as unfounded (Dalmasso et al., 2011; de Freitas et al., 2015; 
Falentin et al., 2010; Loux et al., 2015; Thierry et al., 2011), and the subspecies 
names were proposed to be considered synonyms of the species P. 
freudenreichii (Scholz and Kilian, 2016). 
P. freudenreichii was originally isolated from Swiss-type cheese (van Niel, 
1928), where it is currently used as a ripening culture. Its primary role in the 
cheese is to remove lactic acid that is produced by the lactic acid bacteria 
starter strains. Metabolism of lactic acid by Propionibacteria results in the 
production of the short-chain fatty acids propionate and acetate, as well as in 
the production of CO2. Production of CO2 is crucial for the formation of the 
typical, large, round eyes in Emmental cheese (Daly et al., 2010). The main 
contribution of P. freudenreichii to flavour development during cheese 
ripening is through hydrolysis of lipids and the release of amino acids (most 
notably proline) and volatile compounds (Vorobjeva, 1999b). The lipolytic 
activity of P. freudenreichii accounts for over 90% of free fatty acids released 
during ripening and consequently plays a major role in the development of the 
typical flavour associated with Swiss-type cheeses (Dherbecourt et al., 2010). 
Evidence of its long, safe use in cheeses resulted in granting the status of 
Generally Recognised as Safe (GRAS) to P. freudenreichii (Falentin et al., 
2010; Meile et al., 2008). 
Aside from its role in the dairy industry, P. freudenreichii is also used for 
the industrial production of vitamin B12. Vitamin B12 is one of the most 
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complex non-polymeric molecules found in nature and the most complex 
vitamin. Due to the complexity and cost of the chemical synthesis of vitamin 
B12, which requires approximately 70 steps, the vitamin is produced 
exclusively through microbial fermentation by some of the few synthesising 
species of bacteria and archaea (Martens et al., 2002). 
Vitamin B12 deficiency is associated with multiple neurological 
symptoms, ranging from forgetfulness and fatigue to severe and irreversible 
neurological disorders (Reynolds, 2006). Vitamin B12 is primarily found in 
animal-derived foods. Therefore, vegetarians and populations with limited 
intake of such foods are at risk for developing deficiency (EFSA NDA Panel, 
2015; Pawlak et al., 2013). The current trend towards introducing more 
sustainable diets with reduced consumption of animal-derived foods 
(Perignon et al., 2017) is likely to put a wider population at risk for vitamin B12 
deficiency, unless such deficiencies are corrected by supplementation (Eshel 
et al., 2016).  
In recent years, natural fortification of foods in vitamins produced by 
food-grade bacteria was suggested as a potential way to increase the 
nutritional value of food products without increasing production costs 
(Burgess et al., 2009). At the same time, it would allow consumers to enhance 
their vitamin intakes from a normal diet (LeBlanc et al., 2011) and eliminate 
the need for food supplementation with chemically synthesised vitamins 
(Capozzi et al., 2012). P. freudenreichii is the only GRAS bacterium known to 
synthesise active vitamin B12 and is therefore a viable candidate to be 
considered for the in situ fortification of foods. 
Despite the recognised role of P. freudenreichii in the dairy industry and 
its ability to produce vitamin B12, the bacterium remained poorly 
characterised on a genomic level, with only one whole genome sequence 
(Falentin et al., 2010) publicly available for the species at the beginning of this 
project. The most likely reason for this is the character of the P. freudenreichii 
DNA, which has a high GC% content and stretches of repeated sequences, two 
known factors that hamper the sequencing (Huptas et al., 2013) and assembly 
of bacterial genomes (Koren et al., 2013), respectively. 
In this thesis, the applicability of P. freudenreichii for in situ fortification of 
foods in active vitamin B12 is explored using multiple approaches. First, the 
activity of the BluB/CobT2 enzyme is assessed to determine its role in the final 
steps of the biosynthetic pathway of active vitamin B12 in P. freudenreichii. 
Subsequently, the roles of precursor supplementation on the increased 
production of B12 are explored. Finally, the ability of P. freudenreichii to 
produce active vitamin B12 without supplementation is tested in food-like 
growth media. Additionally, the suitability of the Pacific Biosciences (PacBio) 
RS II sequencing platform for overcoming the challenges posed by the DNA of 
P. freudenreichii is shown. The platform is then employed for whole genome 
sequencing of 18 additional strains, and a comparative genomics study is 
undertaken to better characterise the species on a genomic level.  
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 REVIEW OF THE LITERATURE 
2.1 VITAMIN B12 
Vitamin B12 (Figure 1) belongs to a group of compounds known as 
cobamides, which are structurally related to compounds such as haeme and 
chlorophyll. The characteristic features of a cobamide include the structure of 
the corrin ring, which is decorated with multiple methyl, acetamide and 
propionamide side chains, and a cobalt ion that is coordinated in the centre of 
the ring. Additionally, the structure possesses two axial ligands that are 
coordinated to the central cobalt ion: the upper and the lower ligands. In 
cobalamins, which are the cobamides with vitamin B12 activity, the lower 
ligand consists of 5,6-dimethylbenzimidazole (DMBI), which is extended 
through an α-glycosidic link to ribose-3-phosphate (the pseudonucleotide) 
(Ball, 2006, Roth et al., 1996). The upper ligands of cobalamins vary and 
include methyl, hydroxyl, adenosyl and cyano groups, resulting in the 
corresponding names of methylcobalamin, hydroxocobalamin, 
adenosylcobalamin and cyanocobalamin (Ball, 2006; Martens et al., 2002). 
 
The name vitamin B12 refers to the form with the cyano ligand, which does 
not occur in nature but is formed from other cobalamins during extraction 
with sodium cyanide (Battersby and Leeper, 1999). The other cobalamins are 
converted to the cyanocobalmin to increase stability, which protects the 
vitamin from degradation during heat extraction (Kumar et al., 2010). 
Cyanocobalamin is readily converted into coenzyme forms in the human body 
(Obeid et al., 2015). Because the upper ligand has no effect on the B12 activity, 
all of the cobalamins in this work are referred to as vitamin B12 for simplicity.  
Figure 1 Structure of vitamin B12 with the alternative upper ligands (R) and corresponding names of complete 
vitamin B12 molecules carrying these ligands are shown on the right. The lower ligand DMBI is indicated in a
box 
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2.1.1 ROLE OF VITAMIN B12 IN HUMANS 
Vitamin B12 was discovered by Whipple and concurrently by Minot and 
Murphy as a treatment for “pernicious anaemia” in 1925. Before the isolation 
of vitamin B12 in crystalline form in 1947 (Rickes et al., 1948a), the treatment 
involved eating large portions of raw liver. Dorothy Hodgkin resolved the 
crystal structure of the vitamin in 1956, leading to the extensive research that 
enabled its further characterisation (Banerjee and Ragsdale, 2003).  
In humans, the activity of vitamin B12 is restricted to two enzymes: 
cytoplasmic methionine synthase and mitochondrial methylmalonyl-CoA 
mutase. Methionine synthase uses methylcobalamin form of vitamin B12 as a 
co-factor in methylation of homocysteine to methionine, with concurrent 
demethylation of 5-methyl-tetrahydrofolate. Thus, methionine synthase plays 
a role in methyl-transfer reactions and in nucleotide synthesis (EFSA NDA 
Panel, 2015; Nielsen et al., 2012; Reynolds, 2006). Methylmalonyl-CoA 
mutase catalyses a methylcobalamin-dependent radical-rearrangement of L-
methylmalonyl-CoA to succinyl-CoA. The reaction plays an important role in 
the metabolism of branched-chain amino acids and odd-chain fatty acids by 
directing them to the tricarboxylic acid (TCA) cycle (Nielsen et al., 2012; 
Watanabe et al., 2013). 
2.1.1.1 Vitamin B12 deficiency  
In its severe form, vitamin B12 deficiency is associated with megaloblastic 
anaemia and irreversible, severe neurological disorders, whereas the milder 
form can present with non-specific symptoms such as lethargy, forgetfulness, 
infertility or depression (Reynolds, 2006). Due to the lack of specificity in the 
symptoms, the deficiency is diagnosed through biological markers. The 
markers that are measured include serum levels of methylmalonic acid and/or 
homocysteine (Stabler, 2013) and holo-transcobalamin II (a protein that 
transports vitamin B12 that is absorbed in the ileum to cells in the body) 
(Nielsen et al., 2012; Pawlak et al., 2013); preferably, a combination of at least 
two of these markers is used for diagnostics (EFSA NDA Panel, 2015). 
Vitamin B12 deficiency can stem from either extended inadequate intake or 
from impaired transport and metabolism. Because vitamin B12 predominantly 
occurs in animal-derived foods, the deficiency due to the extended inadequate 
intake is the most common among vegetarians (EFSA NDA Panel, 2015, 
Pawlak et al., 2013, Watanabe et al., 2013), and consequently, in the infants of 
vegetarian mothers (Black, 2008; Green and Miller, 2013). The impaired 
transport and metabolism can be a result of genetic disorders, which are 
relatively rare (Carmel, 2008; Green and Miller, 2013), or due to Intrinsic 
Factor (IF)-related malabsorption (EFSA NDA Panel, 2015). IF is a 
glycoprotein that is produced by the parietal cells of the stomach. IF is 
responsible for binding to vitamin B12 and transporting it to the ileum, where 
the IF-bound vitamin B12 is transported into the epithelial cells (Nielsen et al., 
2012). IF-related malabsorption can result from its insufficient synthesis 
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(pernicious anaemia developing due to autoimmune disorders) or from failure 
of the ileal uptake (Carmel, 2008).  
For the prevention of deficiency due to inadequate intake in Europe, the 
European Food Safety Authority (EFSA) set the adequate intake (AI) levels at 
1.5 μg/day for children aged 7 months to 6 years, 2.5 μg/day for ages 7-10 
years, 3.5 μg/day for ages 11-14 and 4 μg/day for ages 15 and above. For 
pregnant and breastfeeding women, AI was increased to 4.5 and 5 μg/day, 
respectively (EFSA NDA Panel, 2015). In the USA, the recommended dietary 
allowance (RDA) was set by the US Institute of Medicine at 2.4 μg/day for 
persons over 14 years of age (National Institutes of Health, 2016). In the cases 
of impaired transport, megadoses of vitamin B12 as dietary supplements are 
recommended because it is estimated that approximately 1-2% of the vitamin 
can be absorbed through passive transport (EFSA NDA Panel, 2015). It was 
reported that long-term daily doses of up to 5 mg of vitamin B12 have no 
adverse effects (EFSA NDA Panel, 2015). However, vitamin B12 and related 
compounds have recently been shown to play a role in modulation of the 
human gut microbiota (Degnan et al., 2014a). To date, the specific effects of 
this modulation on human health remain unknown.  
2.1.2 VITAMIN B12 IN FOODS 
Vitamin B12 is synthesised solely by microorganisms, including species 
found in soil, water, and sewage and also in the rumen and intestines of 
animals. Therefore, in animal-derived foods, vitamin B12 can originate either 
from the animal’s own digestive tract or from ingestion of vitamin B12-
producing microorganisms or animal tissue. In plant-based foods, vitamin B12 
can occur naturally due to microbial contamination or, in legumes, through 
symbiosis with B12-producing microorganisms (Ball, 2006). Alternatively, the 
vitamin can be introduced through fermentation by B12-producing 
microorganisms (EFSA NDA Panel, 2015). The vitamin B12 content of several 
common foodstuffs, as reported by the US Department of Agriculture (USDA), 
is listed in Table 1 (USDA, 2016). The foodstuffs which have been previously 
suggested as sources of vitamin B12 for vegetarians and vegans (Watanabe et 
al., 2013) are included in the list, and it is clear that these food products are 
not particularly vitamin B12-rich. This, combined with the fact that some 
vegetarians reportedly refuse to take vitamin supplements due to various 
beliefs (Antony, 2003; Pawlak et al., 2013), calls for alternative measures for 
introducing vitamin B12 into everyday diets. 
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Table 1 Vitamin B12 content in some foodstuffs as reported by USDA. Food products suitable for lacto-ovo-
vegetarians are marked in bold, while foods suitable for vegans are additionally underlined 
Foodstuff Vitamin B12 (μg/100g) 
Clams (steamed) 99.1 
Mussels (steamed) 24.0 
Breakfast cereal (B12 fortified) 20.0 
Mackerel (Atlantic, cooked, dry-heat) 19.0 
Swiss cheese 3.0 
Salmon (chinook, cooked, dry-heat) 2.8 
Beef (lean, plate steak, cooked, grilled) 2.1 
Brie cheese 1.7 
Rockfish (cooked, dry-heat) 1.6 
Turkey (cooked, roasted) 2.0 
Ham (cured, roasted) 0.7 
Egg (poached) 0.6 
Yoghurt (fruit, low fat) 0.5 
Milk (skim) 0.4 
Chicken (light meat, cooked, roasted) 0.4 
Seaweed (rehydrated) 0.3 
Mushrooms (brown, Italian) 0.1 
Tempeh 0.08 
 
2.1.2.1 B12 biosynthesis for in situ fortification of foods 
In situ fortification of foods in vitamins by fermentation with food-grade 
bacteria has been suggested as a potential way to increase the nutritional value 
of food products without increasing production costs (LeBlanc et al., 2011) 
while simultaneously eliminating the need for food supplementation with 
chemically synthesised vitamins (Capozzi et al., 2012). In recent years multiple 
attempts have been made towards vitamin B12 production in foods (Bhushan 
et al., 2017; De Angelis et al., 2014; Edelmann et al., 2016; Gu et al., 2015; 
Molina et al., 2012; Van Wyk et al., 2011). 
The food-grade bacteria that are considered for their ability to produce 
vitamin B12 include the GRAS status-holding Lactobacilli, among them 
Lactobacillus reuteri (Taranto et al., 2003), Lactobacillus plantarum 
(Bhushan et al., 2017), and Lactobacillus rossiae (De Angelis et al., 2014) and 
also P. freudenreichii and the recommended for Qualified Presumption of 
Safety (QPS) (Leuschner et al., 2010; EFSA BIOHAZ Panel, 2012) 
Acidipropionibacterium acidipropionici (Parizzi et al., 2012). 
2.1.2.2 Distinguishing active vitamin B12 from other cobamides 
Historically, the levels of vitamin B12 have been assessed using the 
microbiological bioassay (MBA) (Degnan et al., 2014b). The MBA method is 
based on measuring the level of growth of a microorganism that is auxotrophic 
for vitamin B12, such as Lactobacillus delbrueckii (previously leichmannii) 
ATCC 7830 (Chamlagain et al., 2015; Quesada-Chanto et al., 1998), where the 
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growth level is assumed to correspond to the measurable amount of vitamin 
B12. Although the method is officially approved and frequently used, it is not 
suitable for measuring active vitamin B12, as it is not capable of distinguishing 
between different corrinoids or other compounds that stimulate the growth of 
the test bacteria (Ball, 2006; Degnan et al., 2014b). Over time, several methods 
with increased suitability have been developed, and chromatography-mass 
spectrometry methods are currently recommended for measuring vitamin B12. 
These methods are able to separate and distinguish the active vitamin B12 from 
related compounds (Allen and Stabler, 2008; Chamlagain et al., 2015; Degnan 
et al., 2014b). From the perspective of food fortification, it is crucial that 
vitamin B12 is produced in its active form with DMBI as the lower ligand, as 
other forms have many fold lower affinities to the IF glycoprotein, making 
them unavailable to humans (Stupperich and Nexø, 1991). 
2.2 BIOSYNTHESIS OF VITAMIN B12  
Chemical synthesis of vitamin B12 has been achieved (Eschenmoser and 
Wintner, 1977). However, the process is so technically challenging, and 
therefore so expensive, that the production of vitamin B12 is restricted to 
biosynthetic fermentation by microorganisms (Murooka et al., 2005).  
Biosynthesis of vitamin B12 can be divided into three stages: 1) biosynthesis 
of δ-aminolevulonic acid (ALA), 2) assembly of the corrin ring and preparation 
for the attachment of the lower ligand, and 3) formation and activation of the 
lower ligand.  
2.2.1 BIOSYNTHESIS OF ALA 
There are two known biosynthetic pathways for ALA: C4 and C5 (Figure 2).  
In the C4 pathway, also known as the Shemin pathway, ALA is formed in a 
one-enzyme condensation reaction of glycine and succinyl coenzyme-A by the 
ALA synthase (ALAS) (Menon and Shemin, 1967; Piao et al., 2004). The 
Shemin pathway is utilised by animals, fungi and only a few bacteria, including 
α-proteobacteria such as Rhodobacter sphaeroides (Piao et al., 2004) and 
Figure 2 Biosynthesis of ALA through C4 and C5 pathways. 
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Rhodobacter capsulatus (Zappa et al., 2010), but also in Pseudomonas 
denitrificans (Blanche et al., 1995), Streptomyces nodosus subsp. asukaensis 
(Petříček et al., 2006) and P. freudenreichii (Menon and Shemin, 1967).  
In the C5 pathway, ALA is formed in three steps: ligation of tRNA to L-
glutamate, reduction of the formed glytamyl-tRNA to glutamate 1-
semialdehyde by glutamyl tRNA reductase (HemA) (Piao et al. 2004), and 
subsequent transamination by a glutamate semialdehyde aminomutase 
(HemL) to generate ALA (Murakami et al., 1993; Piao et al., 2004).  
The C5 pathway is utilised by higher plants and algae (Battersby and 
Leeper, 1999), and it is widespread among bacteria including Escherichia coli 
(Verderber et al., 1997), Salmonella enterica (Elliot and Roth, 1989) and P. 
freudenreichii (Hashimoto et al., 1996; Oh-hama et al., 1993; Piao et al., 
2004). Some bacteria have been reported to utilise both pathways (Avissar et 
al., 1989; Iida and Kajiwara, 2000; Petříček et al., 2006). 
2.2.2 ASSEMBLY OF THE CORRIN RING 
The assembly of the corrin ring proceeds from condensation of two ALA 
molecules into porphobilinogen; four molecules of porphobilinogen are 
polymerised, rearranged and cyclised to uroporphyrinogen III (Figure 3A). 
After formation of uroporphyrinogen III, the biosynthetic pathways of 
chlorophyll and haeme diverge, while the vitamin B12 pathway continues 
through methylations to precorrin-2 (Martens et al., 2002; Warren et al., 
2002). The complete B12 biosynthetic pathway is present only in some species 
of bacteria and archaea and proceeds through two alternative routes: an 
oxygen-dependent and oxygen-independent route. The oxygen-dependent 
route has been described in detail for P. denitrificans (Blanche et al., 1995; 
Warren et al., 2002), and the oxygen-independent pathway was elucidated for 
S. enterica (Roth et al., 1993), P. freudenreichii (Roessner et al., 2002), and 
Bacillus megaterium (Moore et al., 2013). The major differences between the 
pathways are the timing of the cobalt insertion into the corrin ring and the 
method of ring contraction (Warren et al., 2002). In the oxygen-independent 
pathway, cobalt is inserted already into precorrin-2 (Martens et al., 2002), 
where it assists in the ring contraction; in the oxygen-dependent pathway, the 
insertion of cobalt step occurs only after the ring is contracted in what is 
typically an oxygen-dependent manner (Warren et al., 2002). With the cobalt 
inserted in the centre and with the corrin ring contracted, the two pathways 
rejoin at the formation of adenosyl-cobyric acid, to which an aminopropanol 
arm is added to form adenosylcobinamide (Figure 3B), which at that point is 
only missing the lower ligand to complete the vitamin B12 molecule (Martens 
et al., 2002). For the lower ligand to be attached, the aminopropanol arm of 
adenosyl-cobinamide needs to be activated by guanosine triphosphate (GTP), 
which results in the attachment of guanosine diphosphate (GDP). Thus, 
activated adenosyl-cobinamide-guanosine pyrophosphate is ready for the 
attachment of the lower ligand, which is formed and activated in a separate 
pathway (Warren et al., 2002). 
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2.2.3  FORMATION AND ACTIVATION OF THE LOWER LIGAND 
In vitamin B12, the lower ligand is formed from the DMBI base. DMBI can 
be synthesised in an oxygen-dependent manner from flavin mononucleotide 
(FMN) by bacteria that possess the bluB gene (Taga et al., 2007; Gray et al., 
2007; Collins et al., 2013) or in an oxygen-independent manner from glycine, 
glutamine, formic acid and erythrose (Renz, 1998). The oxygen-independent 
formation of DMBI was recently described in Eubacterium limosum and tied 
to the activity of the products of the bzaABCDE gene cluster (Hazra et al., 
2015). Prior to attachment as a lower ligand, the DMBI base needs to be 
activated into α-ribazole phosphate (α-RP) (Figure 4A) by the attachment of a 
phosphoribose moiety that is donated by nicotinic acid mononucleotide 
(NaMN) or a related molecule through the action of a CobT enzyme (Crofts et 
al., 2013). Only then, adenosyl-cobinamide-guanosine pyrophosphate and     
Figure 3 Formation of the corrin ring. Panel A: formation of precorrin-2 from ALA. Precorrin-2 is the first 
intermediate dedicated solely to the production of vitamin B12. It is also the last common intermediate before the 
oxygen-dependent and oxygen-independent pathways diverge; Panel B: preparation of the contracted ring for 
attachment of the lower ligand. The aminopropanyl arm is added to adenosylcobyric acid, the first common 
intermediate after re-joining of the pathways, and it is marked in bold on the molecule of the resulting 
adenosylcobinamide. After activation with GTP, adenosylcobinamide-GDP is ready for attachment of the lower 
ligand. 
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α-RP can form a vitamin B12 molecule (Figure 4 B), which is accompanied by 
the release of guanidine monophosphate (GMP). 
 
 
2.2.3.1 Production of vitamin B12-like compounds 
It has been understood for many years that certain microorganisms can 
produce various cobamides, which are compounds that are structurally related 
to vitamin B12, but can have different lower ligands. Those lower ligands 
include purines, various benzimidazoles, and phenolic compounds (Figure 5) 
(Renz, 1999; Taga et al., 2008). Historically, cobamides were considered as 
substitutes for vitamin B12, which were produced by microorganisms when 
DMBI was unavailable (Taga et al., 2008). Specific cobamides could be 
synthesised in the process of so-called guided biosynthesis, in which bases for 
the desired lower ligand were supplied (Perlman and Barrett, 1958). While this 
appears to be true for some microorganisms, such as S. enterica (Cheong et 
al., 2001), in some microorganisms guided biosynthesis may lead to reduced 
viability (Crofts et al., 2013). Recent in vitro studies have shown that even 
though most the tested CobT enzymes activate DMBI preferentially (Hazra et 
al., 2013), the activation in vivo depends on the preference of the 
Figure 4 Final steps of the vitamin B12 biosynthetic pathway. Panel A: Activation of DMBI for attachment; Panel 
B: Complete molecule of vitamin B12 (in this case adenosylcobalamin). The attached lower ligand together with
the pseudonucleotide appendage are marked in bold 
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microorganism (Crofts et al., 2013). The most notable example shown was that 
of L. reuteri: the CobT enzyme of L. reuteri activated DMBI preferentially in 
vitro (Hazra et al., 2013), and also when heterologously expressed in 
Sinorhizobium meliloti (Crofts et al., 2013). However, when the synthesis by 
L. reuteri was tested in vivo, the bacterium produced solely pseudovitamin 
B12, a corrinoid with adenine as the lower ligand (Santos et al., 2007), even 
when DMBI was provided (Crofts et al., 2013).  
 
Figure 5 Examples of other lower ligands in cobamides. Panel A: Molecule of vitamin B12, with the lower ligand 
DMBI base indicated in a box; Panel B: Benzimidazoles; Panel C: Purines; Panel D: Phenoles. The cobamide 
with adenine as the lower ligand is referred to as pseudovitamin B12.  
2.2.4 B12 PRODUCTION BY P. FREUDENREICHII 
2.2.4.1 Experimental evidence 
Research into the production of vitamin B12 by P. freudenreichii began 
shortly after the discovery of the B12-production capability by microorganisms 
in 1948 (Rickes et al., 1948b). As early as 1951, a patent (U.S. Patent 2715602) 
was filed by Hargrove and Leviton (1955) on a process of B12 production by P. 
freudenreichii. The patent stated that the yields of vitamin B12 depended on, 
aside from growth-promoting carbon and nitrogen sources, the availability of 
cobalt and the levels of oxygen in the culture. The microaerobic conditions 
were deemed the most suitable, and the maximal vitamin B12 yields of 0.8 
μg/mL were reached. Excessive aeration was shown to result in almost 
complete abolition of production.  
In the following patent (Speedie and Hull, 1960, U.S. Patent 2951017), a 
more than ten-fold increase in the vitamin B12 yield was obtained through the 
introduction of a two-step fermentation process. In this process, the cells were 
anaerobically grown for 70 hours, and after that time, air was allowed into the 
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cultures until the completion of fermentation at 168 hours. For the highest 
yields, culture pH was maintained at pH 7 through the addition of ammonia. 
The two-step incubation process was then optimised for production of B12 in 
sweet whey, which was considered a waste product of the dairy industry at the 
time (Bullerman and Berry, 1966a; Bullerman and Berry, 1966b; Berry and 
Bullerman, 1966). It was later established that to maximise yields of vitamin 
B12, DMBI base needed to be added (Martens et al., 2002; Marwaha et al., 
1983; Vorobjeva, 1999c), which rendered P. freudenreichii one of the highest 
natural producers of vitamin B12 (Martens et al., 2002). In the most recent 
studies, the two-step incubation in the whey medium combined with 
supplementation with 5 mg/L of cobalt chloride and 15 mg/L of DMBI was 
used as the optimal method for screening of P. freudenreichii strains for their 
capability to produce vitamin B12 (Hugenschmidt et al., 2010; Hugenschmidt 
et al., 2011). 
It should be noted that for the purposes of in situ food fortification, neither 
cobalt nor DMBI should be specifically added, as neither of these compounds 
has been approved for food applications (Commision Regulation No 1129, 
2011). For this reason, new strategies for vitamin B12 production without these 
additions are needed. 
2.2.4.2 Genetic background 
The genes involved in the complete biosynthetic pathway have been 
deciphered for P. freudenreichii (Table 2). The genes are organized into 4 
clusters (Murooka et al., 2005; Falentin et al., 2010), two of which are 
preceeded by B12 riboswitches (Figure 6), while the third riboswitch is located 
ahead of the mutA gene coding for a B12-dependent methlomalonyl-CoA 
mutase, an enzyme involved in energy metabolism through TCA cycle 
(Vitreschak et al., 2003). The discovery and characterisation of genes that are 
responsible for ALA synthesis, hemA and hemL, support the previously 
reported presence of the C5 pathway (Hashimoto et al., 1997). Although both 
ALA biosynthetic pathways have been reported in P. freudenreichii (Iida et al., 
2001), no hemAs that encodes ALAS has been found. The studies of the genes 
involved in the formation of the corrin ring confirm the oxygen-independent 
cobalt insertion pathway (Roessner et al., 2002), which is also supported by 
biochemical studies, regardless of the presence of oxygen (Iida et al., 2007). 
Genome mining of the first complete genome of P. freudenreichii led discovery 
of the bluB/cobT2 fusion gene (Falentin et al., 2010). The predicted activity of 
the gene product points to the formation of the lower ligand DMBI from FMN 
in the oxygen-dependent reaction (Taga et al., 2007), however this ability 
needs to be confirmed experimentally. 
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Table 2 Vitamin B12 biosynthetic genes identified in P. freudenreichii. The annotations and loci are derived from 
the whole genome sequence NC_014215.1 (Falentin et al., 2010). The organisation of the gene clusters can be 
seen in Figure 6 
 
 
Figure 6 The four gene clusters in which majority of the vitamin B12 biosynthetic genes are organised in P. 
freudenreichii. B12 riboswitches can be seen upstream of genes cbiL and cbiB. Figure adapted from Falentin et al. 
(2010) and Polaski et al. (2016). 
 
Cluster 
Gene 
name Locus ID Annotation 
Cobalt 
transport I cobA PFREUD_RS02240 uroporphyrinogen-III C-methyltransferase 
I cbiO1 PFREUD_RS02245 cobalt ABC transporter ATP-binding protein 
I cbiQ PFREUD_RS02250 cobalt ECF transporter T component  
I cbiN PFREUD_RS11710 
cobalt ABC transporter substrate-binding 
protein  
I cbiM PFREUD_RS02260 cobalt transporter  
ALA synthesis N/A hemA PFREUD_RS09010 glutamyl-tRNA reductase 
N/A hemL PFREUD_RS08965 glutamate-1-semialdehyde 2,1-aminomutase 
Assembly and 
activation of the 
corrin ring 
IV hemB PFREUD_RS08980 delta-aminolevulinic acid dehydratase 
IV hemC PFREUD_RS09005 hydroxymethylbilane synthase 
N/A hemD PFREUD_RS09540 uroporphyrinogen-III synthase 
II cysG PFREUD_RS03785 cobalamin biosynthesis protein 
II cbiL PFREUD_RS03770 precorrin-2 C(20)-methyltransferase 
II cobJ PFREUD_RS03780 tetrapyrrole methylase 
II cbiF PFREUD_RS03775 precorrin-4 C(11)-methyltransferase 
II cbiD PFREUD_RS03790 cobalt-precorrin-5B (C(1))-methyltransferase 
II cbiJ PFREUD_RS03805 cobalt-precorrin-6A reductase 
II cbiT PFREUD_RS03800 
precorrin-6Y C5,15-methyltransferase 
(decarboxylating) subunit  
II cbiC PFREUD_RS03795 precorrin-8X methylmutase 
III cbiA PFREUD_RS05920 cobyrinic acid a,c-diamide synthase 
III cobA2 PFREUD_RS05915 
cob(I)alamin adenolsyltransferase/cobinamide  
ATP-dependent adenolsyltransferase 
III cbiP PFREUD_RS05910 cobyric acid synthase  
III cbiB PFREUD_RS05905 adenosylcobinamide-phosphate synthase 
III cobU PFREUD_RS05925 
adenosylcobinamide 
kinase/adenosylcobinamide phosphate 
guanyltransferase 
III cobS PFREUD_RS05930 cobalamin synthase 
III cobB PFREUD_RS05935 TetR family transcriptional regulator 
Synthesis and 
activation of 
DMBI N/A 
bluB/ 
cobT2 PFREUD_RS03140 5,6-dimethylbenzimidazole synthase 
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2.3 GENOMICS OF P. FREUDENREICHII 
The first attempt at sequencing P. freudenreichii DSM 4902 (CIRM-BIA1) 
was publicly announced in 2004 (Meurice et al., 2004). The genome 
sequencing was completed and announced in 2010 (Falentin et al., 2010). The 
project shed light on multiple features of P. freudenreichii, including the 
genetic basis for the species hardiness and long-term survival. In addition, the 
metabolic pathways that are involved in the production of the bifidogenic 
factor and the formation of the propionic acid as well as other compounds that 
are important for flavour development in cheese were also described (Falentin 
et al., 2010). The study also identified several misconceptions about the 
species. For example, the presence of all the genes that were necessary for 
aerobic respiration was demonstrated, even though the species was generally 
grown under an anaerobic or microaerobic atmosphere. Despite the species is 
associated with the dairy environment, it is poorly adapted to growth in milk, 
but adaptation to the gut environment and probiotic properties were detected. 
Although the strain was classified at that time as belonging to the subspecies 
shermanii, identification of genomic islands in the strain led to the first 
challenge of the subdivision of the species into subspecies freudenreichii and 
shermanii on the basis of phenotypic characteristics: utilisation of lactose and 
reduction of nitrate. The genes coding for β-galactosidase, the galactoside 
transporter and UDP-glucose isomerase were all located on an island and were 
most likely acquired through horizontal gene transfer, possibly from cow 
rumen-associated bacteria. The inability to reduce nitrate was attributed to a 
frameshift in the beta subunit of nitrate reductase that turned it into a 
pseudogene (Falentin et al., 2010). The species subdivision was recently 
deemed not warranted (Scholz and Kilian, 2016). 
In the following study, genomes of 21 strains were sequenced and 
assembled into draft genomes using the P. freudenreichii DSM4902 genome 
as the reference (Loux et al., 2015). An additional draft genome of the probiotic 
strain P. freudenreichii ITG P20 was subsequently published (Falentin et al., 
2016). The draft genome data were used for various comparative and 
functional studies, including the genetic background of carbohydrate 
utilisation patterns (Loux et al., 2015), adaptation to long-term survival under 
nutrient shortage (Aburjaile et al., 2016) and a further challenge of the division 
into subspecies (De Freitas et al., 2015). 
While informative, the use of draft genomes has provided an incomplete 
view of the studied strains. In draft genomes information on large-scale 
structural rearrangements, segmental duplications and inversions or 
horizontal gene transfer of mobile elements is lost because of their absence 
from the reference genome (Chin et al., 2013). The whole genome sequencing 
of P. freudenreichii was most likely restricted by the high GC% content of the 
DNA and the abundance of stretches of repeated sequences that hindered the 
sequencing and de novo assembly, respectively. However, the rapid 
development of new sequencing platforms constantly opens new sequencing 
possibilities.  
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2.3.1 SUITABLE PLATFORMS FOR THE WHOLE GENOME 
SEQUENCING OF P. FREUDENREICHII 
The platform used for sequencing of the draft genomes of P. freudenreichii, 
Illumina (Loux et al., 2015), relies on Polymerase Chain Reaction (PCR) 
amplification of the DNA sample prior to sequencing, rendering it prone to the 
so-called GC bias. Even though the most recent Illumina MiSeq library 
preparation can be conducted without the use of PCR, the performance on 
high GC% content genomes (≥64 GC%) remains considerably lower than for 
low and medium GC%-rich genomes (35-52 GC%) (Huptas et al., 2016). 
Additionally, one of the greatest obstacles to whole genome sequencing in P. 
freudenreichii are the long stretches of sequences that are rich in repeats. The 
longest repeat-rich sequences found in all prokaryotic genomes are the 
ribosomal DNA (rDNA) operons, which range in size from 5 to 7 kbp (Huptas 
et al., 2016) and can be found as multiple copies (Treangen et al., 2009). 
Additional repeat sequences in prokaryotes generally arise through 
recombination processes such as the site-specific integration of prophages, 
transposition of transposable elements, gene duplication or the actions of 
systems such as retroelements and clustered regularly interspaced 
palindromic repeats (CRISPR), and the arising repeat sequences can greatly 
vary in size (Treangen et al., 2009). It is then assumed that a read size that is 
capable of reading through an entire rDNA operon allows for the assembly of 
most microbial genomes (Koren et al., 2013). To date, the longest reads 
produced by the Illumina MiSeq platform are cited as 2x300, with the usable 
quality reads placed within the range of ~150 to 190 bp (Huptas et al., 2016). 
The Illumina’s take on the short-read problem is the TruSeq protocol, in which 
libraries from long stretches of DNA are prepared in parallel and sequenced 
and assembled from short reads to create high-quality synthetic reads that 
reach 18.5 Kbp in size (McKoy et al., 2014). The sequencing is still biased in 
regions where the Illumina chemistry is biased, namely, in sequences with 
high GC% contents and repeats (Lee et al., 2016), meaning that the platform 
is not optimal for the sequencing of Propionibacteria. 
Currently, there are two PCR-independent and long-read platforms 
available on the market: PacBio and MinION. PacBio was released in 2010 by 
Pacific Biosciences, while MinION developed by Oxford Nanopore 
Technologies was released in 2014 (Mikheyev and Tin, 2014). 
PacBio sequencing is based on SMRT (single-molecule, real-time) 
technology. The elongation of the DNA sequence by an immobilised 
polymerase is recorded in real time as light impulses that are emitted when 
either of the four, differentially fluorescent-labelled nucleotides is 
incorporated into the molecule. The sequencing is performed on a single 
molecule that is made circular by the addition of hairpin adaptors and 
therefore sequenced multiple times (in multiple passes) in the forward and 
reverse orientations, without release from the active site of the polymerase. 
The mean read length obtained with the first- generation chemistry-C1 was in 
the range of approximately 1500 bp; the current chemistry-C4 has a mean of 
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over 20 kbp and maximum read length of 60 kbp. The additional advantage of 
the platform is the ability to identify DNA modification patterns, such as 
methylations (Rhoads and Au, 2015). The disadvantages of PacBio upon 
release were the high costs of the sequencer and reagents and the technology’s 
proneness to sequencing error. Currently, several algorithms are available, 
such as the hierarchical genome-assembly process (HGAP) (Chin et al., 2013). 
This algorithm, owing to the random character of the sequencing errors, with 
sufficient coverage improves the accuracy to more than 99.999%. 
The MinION technology takes advantage of specific to each nucleotide base 
changes in the current, when the DNA molecule passes through a membrane-
embedded protein pore. The instrument itself weighs less than 100 g, and it 
operates through a USB port, from which it draws power (Quick et al., 2016); 
at its launch time, its cost was estimated at $1000 (Mikheyev and Tin, 2014). 
While the low accuracy and low throughput are currently an issue for MinION, 
the use of error-correction algorithms like the ones available for PacBio are 
thought to greatly improve the accuracy to approximately 99.5% (Lee et al., 
2016). The undeniable advantages of the instrument, aside from its low cost, 
are its small size and quick generation of results. These advantages enabled its 
use in the 2015 Ebola outbreak in remote regions of West Africa, where results 
were generated in under 24 hours (Quick et al., 2016). 
With the ongoing development of MinION, PacBio is the most suitable 
sequencing platform for high GC% content genomes available to date. 
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 AIMS OF THE STUDY 
The first aim of this study was to assess the suitability of P. freudenreichii 
for in situ fortification of foods in active vitamin B12. To this end, it was first 
determined whether the predicted BluB/CobT2 enzyme could produce and 
activate DMBI for attachment as the lower ligand of vitamin B12. Subsequently, 
the supplementation with riboflavin and nicotinamide, the precursors of 
DMBI, as substitute for supplementation with DMBI was tested. Finally, the 
effect of different growth media on the capability of P. freudenreichii to 
produce active vitamin B12 without supplementation was assessed. 
 
The second aim of this study was to improve characterisation of the P 
freudenreichii species on the genomic level. To accomplish this, the whole 
genome sequencing from long sequence reads with the PacBio sequencing 
platform was used to sequence P. freudenreichii DSM 20271, one of the two 
type strains of the species. After determining the suitability of the method, 18 
additional whole genomes of P. freudenreichii were sequenced and a 
comparative genomics analysis was performed. 
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 MATERIALS AND METHODS 
4.1 BACTERIAL STRAINS AND GROWTH CONDITIONS 
This study was conducted on 32 bacterial strains, 27 belonging to P. 
freudenreichii, three strains of A. acidipropionici, one strain of E. coli and its 
one mutant (Table 3).  
 
Table 3 Bacterial strains used in this work. 
No Strain 
name 
Origin Sequencing 
name 
Other names  Species Study 
1 256 Valio Ltd. - - P. freudenreichii II 
2 257 Valio Ltd. JS2 - P. freudenreichii II, III, V 
3 258 Valio Ltd. - - P. freudenreichii II, V 
4 259 Valio Ltd. JS4 - P. freudenreichii II, V 
5 260 Valio Ltd. - - P. freudenreichii II 
6 261 Valio Ltd. JS - P.freudenreichii II, V 
7 262 Valio Ltd. - P2, 482 P. freudenreichii II 
8 263 Valio Ltd. JS7 P4, 474 P. freudenreichii II, V 
9 264 Valio Ltd. JS8 - P. freudenreichii II, V 
10 265 Valio Ltd. JS9 - P. freudenreichii II, V 
11 266 cheese JS10 - P. freudenreichii II, V 
12 274 Senson Oy JS11 E-113198 P. freudenreichii II, V 
13 275 Senson Oy JS12 E-113199 P. freudenreichii II, V 
14 276 Senson Oy JS13 E-113200 P. freudenreichii II, V 
15 277 Senson Oy JS14 E-113201 P. freudenreichii II, V 
16 278 Senson Oy - JS278, E-113202 A. acidipropionici II 
17 279 Senson Oy - JS279, E-113203 A. acidipropionici II 
18 280 Senson Oy - JS280, E-113204 A. acidipropionici II 
19 281 DSM JS15, 
CIRM-BIA1 
DSM 4902, NCDO 
853, ATCC 9614, CIP 
103027 
P. freudenreichii I, II, V  
20 282 DSM JS16,  
DSM 20271 
NCDO 564, ATCC 
6207, CIP 103026 
P. freudenreichii II, IV, V 
21 283 Valio Ltd. JS17 - P. freudenreichii II, V 
22 284 Valio Ltd. JS18 P15-90 P. freudenreichii II, V 
23 285 Valio Ltd. - P190 P. freudenreichii II 
24 286 Valio Ltd. JS20 - P. freudenreichii II, V 
25 287 Valio Ltd. JS21 PS145 P. freudenreichii II, V 
26 288 Valio Ltd. JS22 - P. freudenreichii II, V 
27 289 Valio Ltd. JS23 - P. freudenreichii II, V 
28 290 Valio Ltd. - - P. freudenreichii II 
29 291 Valio Ltd. JS25 - P. freudenreichii II, V 
30 292 Valio Ltd. - - P. freudenreichii II 
31 KRX Promega 
 
- E. coli I 
32 PD3 study I 
 
KRX pFN18A-
bluB/cobT2 
E. coli I 
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Twenty P. freudenreichii strains were obtained from the dairy company Valio 
Ltd., one was isolated from a commercial cheese starter. Four strains were 
isolated from barley grains by the malting company Senson Oy, together with 
the three A. acidipropionici strains. The two type strains were purchased from 
the culture collection Deutsche Sammlung von Mikroorganismen und 
Zellkulturen.  
The P. freudenreichii strains were grown in either yeast extract-lactate based 
medium (YEL) (transmission electron microscopy and adhesion assay, study 
V), its variation propionic medium (PPA) (study I, III, IV, V) or in the 
industrial-type whey-based medium (WBM) (study II and III.). A. 
acidipropionici strains were grown in WBM (study II). The strains were 
routinely cultured at 30 °C. The cultures were always started by streaking from 
glycerol (15%) stocks, which were maintained at -80 °C, onto solid medium 
and grown for 4 days in anaerobic jars (Anaerocult, Merck). Subsequently, 
liquid precultures were inoculated from well-separated colonies and grown for 
3 days under a microaerobic atmosphere, while the experimental cultures were 
routinely inoculated at the level of OD600= 0.05 and grown for 3-7 days under 
a microaerobic atmosphere.  
E. coli strains were grown on Luria-Bertani medium (LB), with 100 μg/mL 
ampicillin when needed, at 37 °C or 25 °C, under aerobic atmosphere with 
shaking at 275 RPM. 
4.2 PRODUCTION AND ANALYSIS OF VITAMIN B12 
4.2.1 GUIDED BIOSYNTHESIS (STUDY I) 
To study the preference of P. freudenreichii DSM 4902 towards production 
of the active vitamin versus pseudovitamin, the cultures were supplemented 
with lower ligand bases DMBI (100 μM) or adenine (100 μM); control cultures 
received no supplementation. Three biological replicates were performed for 
all cultures. To ensure efficient formation of the corrin rings, 5 μg/mL cobalt 
chloride was added to all conditions. The cultures were incubated statically 
under a normal atmosphere (microaerobic condition) or in an anaerobic 
chamber (Don Whitley Scientific) for 7 days after which samples were 
harvested for analysis of cobamides. 
4.2.2 SUPPLEMENTATION WITH DMBI PRECURSORS (STUDY II) 
To study the capability of Propionibacteria and Acidipropionibacteria to 
synthesise DMBI, cultures of 27 P. freudenreichii and three A. acidipropionici 
(see Table 3) strains were grown in WBM medium with 5 mg/L CoCl2, 
supplemented with DMBI precursors: riboflavin (40 mM) and nicotinamide 
(27 mM). For comparison, cultures with DMBI (100 mM) added after 6 days 
of incubation (Hugenshmidt et al., 2010) and cultures with only CoCl2 were 
used as controls. The cultures were grown for 7 days in a two-step incubation 
process, where for the first three days, the cultures were grown in static 
cultures under an anaerobic atmosphere (Anaerocult, Merck). Oxygen was 
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then allowed in, and the cultures were incubated for the remaining time with 
shaking (150 RPM; Certomat H, Sartorius) followed by harvesting for the 
cobamide analysis. 
4.2.3 DETECTION OF VITAMIN B12 (STUDY I, II AND III) 
For the detection of all of the vitamin B12-like compounds- cobamides and 
cobinamide, a method described by Chamlagain et al. (2015) was used, with 
some alterations, detailed in subsequent sections. 
4.2.3.1 Extraction (study I, II and III) 
For the extraction of the cobamides and cobinamide, bacterial cells were 
harvested from liquid cultures by centrifugation and 0.1-0.2 g of the bacterial 
pellets were boiled with 10 mL of the extraction buffer (8.3 mM sodium 
hydroxide and 20.7 mM acetic acid, pH 4.5). The buffer contained 100 μL of 
1% NaCN to convert all upper ligands of the cobamides to their most stable 
cyano forms. This was performed to prevent losses of the compounds due to 
heating (Kumar et al., 2010). 
4.2.3.2 Immunoaffinity purification (study I) 
The cell extract was filtered (0.45 μm; Pall) and loaded onto the 
immunoaffinity column (R-Biopharma). The column was then washed with 10 
mL of MilliQ water, and the retentate was eluted with 3.5 mL of methanol and 
evaporated under a stream of nitrogen on a 50 °C heat block. The residue was 
dissolved in 300 μL of MilliQ water and filtered (0.2 μm; Pall) into the LC vial 
(Waters).  
4.2.3.3 UHPLC-PDA (study I, II, III)?
For the analysis of the cobamides and cobinamide, the ultra-high-
performance liquid chromatography (UHPLC) method was used as previously 
described (Chamlagain et al., 2015). Briefly, a Waters UPLC® system (Waters) 
with a C18 column (Waters Acquity HSS T3, 2.1 × 100 mm, 1.8 μm) at a flow 
rate of 0.3 mL/min and a UV detection by a photo diode array (PDA) detector 
at 361 nm was used. The injection volume was 10 μL. B12-like compounds were 
identified based on their retention times and their absorption spectra and 
quantified against the cyanocobalamin standard. In studies II and III, the yield 
of the detected cobamides was expressed in two ways: weight/volume of the 
growth medium and weight/weight of the wet cell mass. 
4.2.3.4 Identification (study I and II) 
To confirm the identity of the cobamides and cobinamide, the extracts were 
analysed using a high-resolution quadrupole time-of-flight (QTOF) mass 
spectrometry (MS) (Synapt G2-Si; Waters) with an electrospray ionisation 
(ESI) interface to the UHPLC system (study I) or an Esquire-LC quadrupole 
ion trap (QIT) mass spectrometer with an ESI interface (Bruker Daltonics) in 
positive ion mode (study II), as previously described (Chamlagain et al., 2015). 
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4.2.4 ACTIVITY OF THE BLUB/COBT2 FUSION ENZYME (STUDY I) 
4.2.4.1 BluB/CobT2 activity reactions (study I) 
The reactions were carried out in 50 μL volumes, containing 5 μM of the 
enzyme, in triplicate. The concentrations of the tested compounds were 100 
μM of FMN with 0, 20 or 40 mM of nicotinamide adenine dinucleotide 
(NADH), 100 μM DMBI, 100 μM adenine, and 200 μM NaMN. The reactions 
were incubated at room temperature and protected from direct light. For the 
reactions containing FMN, dark tubes were used. After the indicated 
incubation time, the reactions were stopped by addition of 6.5% trichloroacetic 
acid. Products were analysed by UHPLC-ESI-MS method. For each reaction, a 
control without the enzyme addition was included. 
4.2.4.2 UHPLC-ESI-MS method for BluB/CobT2 activity reactions 
(study I)  
UHPLC-ESI-MS is detailed in study I. Briefly, the system consisted of a Waters 
Acquity UPLC® I class binary solvent manager, sample manager and column 
thermostat (25 °C), a C18 column (Waters Acquity UPLC® BEH, 2.1 x 50 mm, 
1.7 μm) at a 0.3 mL/min flow rate and a Waters Xevo TQ-S triple quadrupole 
mass spectrometer (Waters). The injection volume was 1 μL. DMBI and 
adenine were quantified against authentic standards, while α-RP and 7-α-D-
ribofuranosyl adenosine 5′phosphate (Ade-RP) were quantified using DMBI 
and adenine as reference standards because authentic standard compounds 
were lacking. 
4.3 2DE AND PEPTIDE IDENTIFICATION (STUDY III) 
The comparative proteome analyses of the P. freudenreichii 2067 (see 
Table 3) cells were performed using two-dimensional gel electrophoresis 
(2DE). Cells were harvested at two growth stages—the mid-exponential 
growth phase and early stationary phase as determined by the growth curve. 
4.3.1 GROWTH CURVE AND SAMPLING TIMES (STUDY III) 
To determine the time needed for cultures grown in the PPA and WBM 
media to reach the mid-exponential growth phase, a growth curve was drawn 
by measuring the optical density (OD) at 600 nm (UV-1800 Shimadzu, 
Ordior) every 4 hours to estimate the time until the mid-exponential growth 
phase was reached (30 hours for PPA and 24 hours for WBM). Subsequently, 
from the experimental cultures grown in the two-step incubation process (as 
described in the previous section), the samples were taken at the mid-
exponential growth phase, at the early stationary phase (72 hours), and after 7 
days (168 hours). The cell samples that were harvested at the first two time 
points were subjected to protein extraction, purification and 2DE, while the 
cobamides from the cells and sugars and acids from the supernatants were 
analysed at all three time points (see below).  
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4.3.2 2DE (STUDY III) 
2DE analyses of P. freudenreichii cells cultured in PPA and WBM were 
done using six biological replicates. The cells were washed with ice-cold 50 
mM Tris-HCl (pH 8.0), disrupted by beating with 0.1 mm glass beads (Sigma 
Aldrich) using Fast-Prep™-24 (MP Biomedical) in three 30-s lysis cycles at 6,5 
m/s and separated by cooling for 1 minute on ice. The samples were purified 
with the 2-D Clean-Up kit (GE Healthcare), and the proteins were quantified 
using the 2D Quant kit (GE Healthcare). Fifty micrograms of protein from each 
sample were solubilised in UTCT buffer. Solubilised proteins were separated 
in the first dimension by isoelectric focusing (IEF) (Ettan IPG phore, GE 
Healthcare) with IPG strips (11 cm, pH 4-7; GE Healthcare) and rehydrated 
overnight in De-Streak solution (GE Healthcare) with 1% IPG buffer pH 4-7 
(GE Healthcare). After the IEF programme completed, the strips were 
equilibrated in equilibration buffers and loaded onto 12.5-% Tris-HCl 
Criterion Precast Gels (BioRad). Separation in the second dimension was run 
using the Criterion Dodeca Cell (BioRad) in Tris-Glycine-SDS buffer (BioRad). 
After electrophoresis, the gels were stained with the SYPRO Orange dye 
(Sigma Aldrich) (1:5000) using a modified protocol described by Malone et al. 
(2001). The images were acquired with the Alpha Imager HP documentation 
system (ProteinSimple). 2DE images were analysed using the SameSpots 
software v4.5 (Totallab). The spots showing fold-changes ≥1.4-1.5 between the 
two conditions (PPA vs. WBM) and with ANOVA p <0.05 were picked for the 
in-gel tryptic digestion and LC-MS/MS analysis. 
4.3.3 IDENTIFICATION OF PEPTIDES (STUDY III)  
The fluorescent 2DE gels were restained with silver nitrate using the mass 
spectrometry-compatible method described by O’Connell and Stults (1997), 
with the acetic acid concentration reduced to 0.5% in the fixing step. The 
selected spots were subjected to trypsin digestion (Shevchenko et al., 1996) 
followed by nano-LC-MS/MS identification (Ultimate 3000 nano-LC, Dionex) 
and QSTAR Elite hybrid quadrupole TOF mass spectrometry (Applied 
Biosystems / MDS Sciex with nano-ESI ionisation, Sciex), as previously 
described (Öhman et al., 2010). 
The nano-LC-MS/MS data were searched through the ProteinPilotTM3.0 
interface (version 2.0.1, Applied Biosystems/MDS SCIEX) using the Mascot 
2.2.03 search algorithm (Matrix Science) against the NCBI database with 
taxonomy set to "Other Actinobacteria (class)". A successful identification cut-
off was set to a significant match (p < 0.05) with at least two peptide hits (ion 
score>40). 
4.4 GENETIC METHODS 
4.4.1 PCR (STUDY I AND V) 
PCR was used for the amplification of the bluB/cobT2 coding region from 
P. freudenreichii DSM 4049 and for detection of the bluB/cobT2 gene in the 
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pFN18A-bluB/cobT2 expression vector and in the E. coli PD3 strain (study I). 
Furthermore, PCR was employed for detection of the bacteriophage in the 
strain JS7 (study V) and confirmation of the duplicated region in strain JS17 
(study V). All PCRs were prepared with the Phusion Mastermix (ThermoFisher 
Scientific), and the primers were ordered from Oligomer Oy. For the 
amplification of DNA from P. freudenreichii, 0.3% of DMSO (ThermoFisher 
Scientific) was used as instructed for high GC% content DNA. After being 
resolved on 0.8% agarose (BioRad), the gels were stained with ethidium 
bromide (0.5 μg/mL) (Sigma-Aldrich) and the results were visualised using 
the Alpha Imager documentation system (ProteinSimple). 
4.4.2 ISOLATION OF GENOMIC DNA (STUDY I, IV, V) 
For the DNA extraction, the Propionibacteria cells from 72 hour cultures 
were harvested by centrifugation for 5 minutes at 21000 g at 4 °C and washed 
once with 0.1 M TRIS-HCl pH 8.0. The DNA extraction was performed with 
the ILLUSTRA™ bacteria genomicPrep Mini Spin Kit (GE Healthcare) with 10 
mg of lysozyme in the lysis buffer and a duration of 30 minutes for the lysis 
step. DNA purity was assessed by spectroscopic measurements with 
NanoDrop 1000 (ThermoFisher Scientific). 
4.4.3 CLONING AND EXPRESSION OF BLUB/COBT2 (STUDY I) 
The bluB/cobT2 coding region (NC_014215.1) was PCR-amplified from P. 
freudenreichii DNA using primers designed to append recognition sites for 
SgfI and PmeI restriction enzymes to the protein-coding region. The amplified 
product was purified with the GenElute™ PCR Clean-Up Kit (Sigma Aldrich). 
The created insert and the Flexi® Vector pFN18A (Promega) were treated with 
the Flexi Enzyme blend (SgfI & PmeI) (Promega) at 37 °C for 2 h. After a 
second purification step, the insert was ligated to the vector with T4 DNA 
ligase M0202S (New England BioLabs). The Single Step KRX Competent Cells 
(Promega) of the E. coli KRX strain were transformed with 25 ng of the 
resulting pFN18A-bluB/cobT2 expression vector and cultured on LB agar with 
100 μg/mL ampicillin. The presence of the bluB/cobT2 coding sequence in the 
clones was confirmed by whole-cell PCR using bluB/cobT2-specific primers. 
The vector from selected clone E. coli PD3 was purified with the GenElute 
Plasmid MiniPrep kit (Sigma Aldrich) and sequenced at the Institute of 
Biotechnology, University of Helsinki, to confirm the correct structure of the 
vector. 
BluB/CobT2 protein overexpression was induced by culturing with 0.1% 
rhamnose. Protein purification was performed per the HaloTag Protein 
Purification System manual (Promega). The expression, solubility and purity 
of the recombinant protein was confirmed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). The enzyme concentration 
was determined with NanoDrop 1000 (ThermoFisher Scientific), and the 
protein was stored in aliquots at -20 °C until use. 
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4.4.4 WHOLE GENOME SEQUENCING (STUDY IV AND V) 
The complete finished genome sequences of 19 P. freudenreichii strains 
were generated at the Institute of Biotechnology, University of Helsinki, with 
the PacBio RS II sequencing platform (PacificBiosciences) using two SMRT 
cells per strain and a 120-min (chemistry P4/C2) or 240-min (chemistry 
P5/C3) movie time. For the de novo assembly of the genomes, HGAP V2 was 
implemented in SMRT Analysis package v.2.1.0 using default parameters, with 
the expected genome size and seed cut-off parameters set to 2,700,000 and 
7,000, respectively (study IV), or the HGAP V3 in SMRT Analysis package 
v.2.3.0 was implemented using default parameters, with the genome size 
estimate set to 3,000,000 bp (study V). Genes were identified using Prodigal 
v2.50 (study IV) or Prodigal v. 2.6.2 (study V) with manual curation in the 
ARGO Genome Browser and submitted to the NCBI (study IV) or European 
Nucleotide Archive (ENA) (study V). 
4.5 BIOINFORMATICS ANALYSES 
4.5.1 SEQUENCE ALIGNMENTS (STUDY I, III AND V) 
Sequence alignments were performed with the BLAST suite on the website 
of the National Center for Biotechnology Information (NCBI). For the newly 
sequenced genome queries, a stand-alone version of the Basic Local Alignment 
Search Tool (BLAST) software on the Biolinux 8 workstation (Field et al. 
2006) was used (study V). For multiple sequence alignments, ClustalW (study 
I) or Clustal Omega (study V) were used. 
4.5.2 COMPARATIVE GENOMICS (STUDY V) 
For the comparative genomics analysis of the 20 genomes, GFF3 
annotation files were generated by PROKKA (Seemann 2014). These files were 
then used as input for Roary (Page et al. 2015) to estimate the core genome 
and pangenome and to identify genes that were unique to each strain. 
4.5.3 GENOME CHARACTERISATIONS (STUDY V) 
Average nucleotide identities (ANI) were calculated using JSpecies V1.2.1 
(Richer and Rosselló-Móra 2009). The EMBL files obtained from ENA were 
converted to the GenBank format with Seqret, which is a part of the EMBOSS 
package on the BioLinux 8 workstation (Field et al., 2006). The obtained files 
were used for visualisation of the genome organisations with the Progressive 
Mauve algorithm in the Mauve alignment tool (Darling et al., 2010). The 
genomic islands were detected using the IslandViewer 3 software (Dhillon et 
al., 2015). Prophages were predicted with the Prophinder (Lima-Mendez et al., 
2008) and Phaster (Arndt et al., 2016) online software and visually reviewed 
for structural completeness. CRISPR loci were identified by CRISPRFinder 
(Grissa et al., 2007) and manually reviewed for co-localisation with the 
CRISPR-associated (Cas) genes. The immunity to known bacteriophages was 
tested by searching the spacer sequences against NCBI-tailed bacteriophages 
Materials and methods 
25 
and the whole nucleotide collection excluding Propionibacteria (txid1743) 
using the BLAST nucleotide (BLASTn) suite (Zhang et al., 2000). The 
restriction-modification (RM) systems were identified with REBASE (Roberts 
et al., 2015) and curated manually by Dr Richard J. Roberts. An automatic 
pilus cluster search was performed using LOCP v. 1.0.0 (Plyusnin et al., 2009), 
followed by a local BLAST protein (BLASTp) (Altschul et al., 1997) search of 
all genomes. The results were visualised with iTOL (Letunic and Bork, 2016), 
Phandango 0.8.5 (Hadfield et al., 2017), EasyFig (Sullivan et al., 2011) 
and PigeonCad (Bhatia and Densmore 2013). 
4.6 OTHER METHODS 
4.6.1 TRANSMISSION ELECTRON MICROSCOPY (STUDY V) 
Negative staining transmission microscopy was employed for the strains in 
which pilus clusters were identified by the LOCP (see below). The strains were 
grown on YEL agar for 7 days. Single colonies were picked and suspended in 
0.1 M 1,4-piperazinediethanesulfonic acid (PIPES) buffer, pH 6.8. A 3 μl 
aliquot was added to Pioloform-coated 200-mesh copper grids (Emitech 
K100X, Emitech Ltd.) and incubated for 1 minute. After that time, excess of 
the suspension was soaked off by a filter paper and the grids were negatively 
stained with 1% neutral uranyl acetate for 15 seconds. After air-drying the 
stained copper grids, the images were acquired at 120 kV with a Jeol JEM-
1400 microscope (Jeol) using an Orius SC 1000B CCD-camera (Gatan).  
4.6.2 ADHESION ASSAY (STUDY V) 
Adhesion of the P. freudenreichii strains (JS, JS16, JS18, JS20 and JS22) 
on immobilized porcine mucin (Sigma-Aldrich) in 96-well Polysorp 
microplates (Nunc Immuno plates, Nunc) was conducted according to Terraf 
et al., (2014) with modifications. The plates were covered with 300 μl of 0.2 
mg/mL mucin in phosphate-buffered saline (PBS) with pH 7.5 (Thermo 
Fischer Scientific) and incubated for 30 min at 37 °C with shaking at 250 rpm 
(PST-60HL Thermo-Shaker, Biosan) and then statically overnight at 4 °C. 
Wells were washed twice with PBS and blocked with 1% bovine serum albumin 
(BSA) in PBS, at room temperature. Replica microplates treated with PBS 
without mucin and then with 1% BSA as above were also prepared to exclude 
BSA-specific binding. After 2 hours of incubation, mucin- and BSA-coated 
wells were washed twice with PBS and allowed to air-dry. For adhesion, 200 
μl of cells suspended in PBS (OD600=2.0) from each strain was added into the 
mucus- and BSA-coated wells, and incubated at 37 °C for 2 hours with shaking 
at 250 rpm. PBS alone was included in all experiments to subtract mucin 
binding by PBS. Non-adherent cells were removed and wells were washed with 
PBS. Then, adherent cells were stained with 200 μL of the crystal violet 
solution (0.1%, w/v) (Sigma–Aldrich, Munich, Germany) for 30 min at room 
temperature. Excess staining was washed with deionized water and the stained 
cells were suspended in 30% acetic acid by shaking at 400 rpm at room 
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temperature, and recorded at 540 nm using an ELISA reader (Labsystems 
Multiskan EX). Up to four independent experiments were performed, each 
with at least sixteen technical replicates. 
Differences between sample and PBS control means were determined by 
one-sample t-test using statistical package program (IBM SPSS Statistics v24 
for Windows, IBM). P values <0.05 were considered statistically significant. 
4.6.3  ANALYSIS OF LACTOSE AND ACIDS (STUDY II AND III) 
Lactose and acids (lactic acid, propionic acid, acetic acid, pyruvic acid and 
succinic acid) were analysed from the growth medium after removal of the 
cells by centrifugation and filtering (0.45 mm; Pall, USA). The analysis was 
performed as reported by Hugenschmidt et al. (2010), with an high-
performance liquid chromatography (HPLC) system equipped with a pump 
(Waters 515), an autosampler, a UV detector set at 210 nm (Waters 717) for 
acids and a refractive index detector (HP 1047A) for lactose run on an Aminex 
HPX-87H column (7.8 300 mm, 9 mm particles; BioRad) at flow rate of 0.6 
mL/min with the injection volume of 40 μL. Quantification was based on 
calibration curves of true standards. In study III, the molar ratios between the 
propionic and acetic acids produced was calculated. 
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 RESULTS AND DISCUSSION 
5.1 PRODUCTION OF ACTIVE VITAMIN B12  
P. freudenreichii is a known producer of vitamin B12 and it is used for 
industrial production of the compound (Martens et al., 2002). However, for 
production at the industrial scale, both cobalt and DMBI are added to 
overcome production bottlenecks. Neither of these compounds can be added 
to food (Commision Regulation No 1129, 2011). Therefore, in studies I, II and 
III the ability of P. freudenreichii to synthesise active vitamin B12 with and 
without the addition of cobalt, DMBI, and other supplements was explored. 
5.1.1 ACTIVITY OF THE FUSION ENZYME BLUB/COBT2 (STUDY I) 
The genes involved in vitamin B12 biosynthetic pathway have been 
described for P. freudenreichii (Murooka et al., 2005; Murakami et al., 1993; 
Roessner et al., 2002; Sattler et al., 1995), except for the stage where the lower 
ligand base, DMBI, is synthesised and activated for attachment as a lower 
ligand of the active vitamin B12. With the publication of the first complete 
genome sequence of P. freudenreichii DSM 4049 (Falentin et al., 2010), a 
bluB/cobT2 fusion gene coding for a putative phosphoribosyl 
transferase/nitroreductase fusion enzyme BluB/CobT2 was discovered. The 
predicted activities of DMBI synthase and nicotinate-nucleotide-DMBI 
phosphoribosyl transferase suggested that P. freudenreichii BluB/CobT2 is 
capable of synthesising and activating DMBI within one enzyme structure, a 
phenomenon not reported before. 
To assess the activity of the fusion enzyme, the bluB/cobT2 gene from one 
of the type strains, P. freudenreichii DSM 4049 (JS15) was cloned and 
overexpressed it in E. coli KRX using the rhamnose-inducible expression and 
purification system, HaloTag® (Promega). Subsequently, in vitro studies with 
the purified enzyme to assess the activity of BluB as a DMBI synthase, along 
with sequential DMBI synthesis and activation by BluB/CobT2 were 
performed and the specificity of CobT2 towards DMBI was tested. Finally, 
guided biosynthesis of cobamides was performed in vivo. 
5.1.1.1 The DMBI synthase activity of BluB 
BluB is responsible for the formation of DMBI from reduced FMN 
(FMNH2) in presence of oxygen (Taga et al., 2007). To reduce FMN to FMNH2, 
a chemical reduction with NADH (Collins et al., 2013) at 0, 20 and 40 mM was 
employed. The analysis of the results by the UHPLC-ESI-MS showed that a 
compound with the expected m/z ratio for DMBI (m/z 147.3) was observed at 
the retention time of 4.05 minutes, which was similar to the true DMBI 
standard (Figure 7). This confirmed the activity of BluB as a DMBI synthase. 
Additionally, only trace amounts of DMBI were detected in the reaction 
without NADH, confirming that FMNH2 was the true substrate for this 
reaction. 
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5.1.1.2 Sequential DMBI synthesis and activation by BluB/CobT2 
After confirming that BluB produced DMBI from FMNH2, a sequential 
reaction containing substrates that were necessary for the synthesis of DMBI 
and its subsequent activation into α-RP, namely FMN, NADH and NaMN was 
performed. The LC-ESI-MS analysis of the reaction products revealed a peak 
with a retention time of 2.75 minutes at m/z 359.1, which corresponded to α-
RP. Because no true standard is commercially available for α-RP, the MS/MS 
fragmentation of the ion at m/z 359.1 was screened and it showed a fragment 
of m/z 147.3 corresponding to DMBI (Figure 8). In the sequential reaction, 
DMBI itself was observed only in trace amounts, even when the highest NADH 
concentration (40 mM) was used, suggesting an efficient activation of the 
produced DMBI into α-RP by BluB/CobT2 (Table 4). 
 
Table 4 The product concentrations of the BluB/CobT2 reactions with FMN and FMN with NaMN at different 
concentrations of NADH. The increase of the product yield with increasing levels of NADH indicate that the 
reduction of FMN was a limiting factor in the reaction. The higher product yields in the sequential reaction and 
the lack of unactivated DMBI point to efficiency benefits of the fusion between BluB and CobT2 enzymes. 
  FMN (100μM) FMN (100 μM) + NAMN (200 μM) 
 NADH (mM) DMBI (nM) α-RP (nM) DMBI (nM) 
0 120.19 ±6.43 - - 
20 1361.61 ±11.67 4458.41 ±200.22 0.54 ±0.18 
40 2300.71 ±8.73 5094.84 ±214.89 1.72 ±0.61 
 
 
Generally, the fusion of two activities in a single polypeptide may be 
beneficial for the enzymatic activity (Ostermeier et al., 2000). In current 
experiments, the molar concentrations of α-RP obtained from the sequential 
Figure 7 The MS spectrum of the product of the reaction of FMN with NADH eluting at 4.05 min. The spectrum 
is identical to that of the DMBI standard. 
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reaction were ~2–3-fold higher than the DMBI concentrations obtained via 
the activity of the BluB reaction alone. It has been previously noted that 
benzimidazoles are only used as the lower ligands of cobamides (Crofts et al., 
2013). The fusion of BluB with CobT2 allows for the efficient use of the 
produced DMBI, which is not required for any other processes in the cell, and 
perhaps positively affects the substrate interaction with the enzyme.  
5.1.1.3 Specificity of CobT2 
From the perspective of vitamin B12 biosynthesis, activation of adenine is of 
particular interest, because adenine activated into Ade-RP would serve as a 
substrate for the lower ligand of the inactive, pseudovitamin B12. Previous 
studies with semi-purified cell extracts of P. freudenreichii suggested that in 
this bacterium CobT-like activities do not include activation of adenine 
(Friedmann 1965; Hörig and Renz, 1980). Conversely, several of the CobT 
homologues studied to date have the ability to activate more than one type of 
Figure 8 The product of the sequential reaction of the BluB/CobT2 enzyme with FMN, NADH and NAMn supplied. 
Panel A: the MS spectrum of the product eluting at 2.75 minutes and expecte m/z ratio for α-RP; Panel B: the
MS/MS fragmentation spectrum of the product. The molecules of DMBI and α-RP are presented next to the ions 
with their corresponding mass to charge ratios (m/z). 
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base into a corresponding α-riboside phosphate, including Ade-RP (Hazra et 
al., 2013).  
For this reason, the ability of the CobT2 enzyme to activate adenine under 
the same conditions that were suitable for the activation of DMBI was tested. 
The UHPLC-ESI-MS analysis of the reaction products resulted in a peak with 
a retention time of 1.25 minutes at m/z 348, corresponding to Ade-RP. 
However, the same peak with a comparable area was detected in reactions with 
the enzyme alone, where no adenine was added. This suggested that the 
observed peak corresponded to 9-β-d-ribofuranosyl adenosine 5′phosphate 
(AMP) rather than to Ade-RP. AMP and Ade-RP are isomers, therefore they 
cannot be distinguished by UHPLC-ESI-MS (Figure 9). The purification 
protocol used for the isolation of the enzyme involved the addition of 
adenosine triphosphate (ATP), which explains the presence of AMP in enzyme 
preparations. The fact that addition of adenine to the reaction did not increase 
the size of the Ade-RP/AMP peak allows conclusion that BluB/CobT2 does not 
react with adenine under the conditions tested. 
5.1.1.4 Guided biosynthesis tests in vivo  
It has been previously shown that the preference of a microorganism 
towards producing a specific cobamide in vivo can differ from the CobT 
activity observed in vitro, as in the case of the L. reuteri CobT enzyme. Based 
on the sequence analysis, the enzyme was predicted to activate both DMBI and 
adenine, which was confirmed by in vitro studies. Additionally, the enzyme 
activated DMBI when heterologously expressed in S. meliloti, a producer of 
active vitamin B12. However, in vivo L. reuteri produced only the 
pseudovitamin (Crofts et al., 2013). 
To confirm the in vitro preference of P. freudenreichii CobT2 to activate 
DMBI, guided biosynthesis tests in vivo were performed. Briefly, the strain 
Figure 9 BluB/CobT2 does not activate adenine into Ade-RP. Panel A: the structures of the isomeric Ade-RP and 
AMP. The compounds differ by the attachment of adenine through 7-α-N-glycosidic bond and 9-β-N-glycosidic 
bond, respectively; Panel B: the LC chromatogram of the reaction with adenine and NaMN (Adenine) shows no 
increase in the peak corresponding to Ade-RP/AMP in relation of the enzyme preparation without reaction 
substrates (Enzyme).  
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was supplied with DMBI and adenine and cultivated under strictly anaerobic 
and microaerobic conditions. After 7 days, the cobamides that were produced 
were analysed. The results showed that under the strictly anaerobic 
atmosphere, no active vitamin B12 was made unless exogenous DMBI was 
added, confirming that oxygen is necessary for the formation of DMBI in P. 
freudenreichii (Figure 10).  
In the cultures where exogenous DMBI was supplied, only active vitamin 
B12 and no pseudovitamin was detected. However, in cultures grown under the 
microaerobic atmosphere without exogenous DMBI, both cobalamin and 
pseudocobalamin were detected, suggesting that DMBI synthesis was a 
limiting factor in the production of vitamin B12 under the growth conditions 
used. Conversely, supplementing the cultures with adenine did not increase 
the levels of pseudovitamin, even under anaerobic conditions, but instead 
cobinamide, a cobamide missing the lower ligand, was detected. These results 
confirm that P. freudenreichii preferentially produces the active form of 
vitamin B12 and that the production of DMBI is the limiting factor in this 
process. 
5.1.2 RIBOFLAVIN AND NICOTINAMIDE AS SUBSTITUTES FOR DMBI 
SUPPLEMENTATION (STUDY II) 
In study II, 30 strains, 27 P. freudenreichii and 3 A. acidipropionici were 
cultivated in a WBM, per the previously tested method aimed at maximising 
Figure 10 The chromatograms of cobamides obtained from P. freudenreichii cultures grown under strictly 
anaerobic (O2-) and microaerobic (O2+) atmospheres, in PPA medium supplemented with only cobalt ions
(Control) or additionally adenine (Ad) or DMBI (DMBI). No active vitamin B12 (2) was detected in cultures grown 
under strictly anaerobic atmosphere and only pseudovitamin B12 was detected (1) unless DMBI was added. Under
microaerobic atmosphere active vitamin B12 was formed, however, pseudovitamin B12 was still produced, showing
that formation of DMBI was a limiting factor. Supplementation with adenine did not increase the amounts of 
pseudovitamin B12 formed compared to control. 
Results and discussion 
32 
vitamin B12 yields (Hugenschmidt et al., 2010). For this reason, the growth 
medium was supplemented with 5 mg/L of CoCl2, and the bacteria were 
cultivated in a two-step fermentation process. In this process bacteria were 
cultivated anaerobically for the first 72 h, and air was subsequently allowed 
into the cultures, which was followed by incubation for 96 hours with shaking. 
Previous studies showed that P. freudenreichii synthesises DMBI from 
riboflavin (Lingens et al., 1992; Renz and Weyhenmeyer, 1972) and that the 
process is enhanced by supplementation with nicotinamide (Hörig and Renz, 
1980). To test whether riboflavin and nicotinamide, the food-grade precursors 
of DMBI, can substitute for DMBI in vivo, cultures supplemented with 40 μM 
of riboflavin and 27 mM of nicotinamide (Hörig and Renz, 1980) were 
prepared. The results were compared to the vitamin B12 yields from the 
cultures to which 15 mg/L (100 mM) of DMBI were added. DMBI was added 
at 144 hours of incubation to prevent inhibition of growth (Hugenschmidt et 
al., 2010, Marwaha et al., 1983). 
5.1.2.1 Bacterial growth in supplemented medium 
All strains tested were able to grow in WBM, with and without the 
supplements (Figure 11A). However, the extent of the growth was strain-
dependent. That dependence may be attributed to the strain’s ability to utilise 
Figure 11 Bacterial growth in WBM (Control) supplemented with DMBI (DMBI), riboflavin (RF) and riboflavin 
together with nicotinamide (RF+NAM). Panel A: OD600 values recorded after 7 days of incubation; Panel B: pH 
values recorded after 7 days of incubation. The starting value was 6.5. 
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lactose, and is reflected by the larger drop of pH from the initial pH 6.5, which 
resulted from production of the propionic and acetic acids during growth 
(Figure 11B)(Details in Study II). 
Notably, the addition of the precursors did not have a detrimental effect on 
bacterial growth, with the exception of the riboflavin and nicotinamide 
combination effect on the growth of two strains, 274 and 276, both of cereal 
origin. Conversely, the addition of both riboflavin and nicotinamide had a 
positive effect on the growth of strains 258, 262, 264 and 281.  
5.1.2.2 Effect of precursors on production of vitamin B12 
All P. freudenreichii strains were capable of producing vitamin B12 in WBM 
with cobalt chloride, the control medium. The vitamin B12 yield ranged from 
0.2 to 5.3 μg/mL, and fell well within the limits reported previously for P. 
freudenreichii (Berry and Bullerman, 1966; Hugenschmidt et al., 2010). The 
A. acidipropionici strains produced the vitamin only when supplemented with 
DMBI, and even then, the production levels were the lowest of all strains and 
conditions tested (Figure 12). DMBI supplementation enhanced vitamin B12 
production in seven of the P. freudenreichii strains (256, 257, 281, 283, 288, 
289 and 290).  
Figure 12 Amount of vitamin B12 accumulated in the bacterial cells calculated per mililiter of culture. The strains 
are grouped according to their response to supplementation. 
Addition of riboflavin alone did not increase B12 production by the strains, 
which was attributed to the ~6.6 mM of riboflavin present in the native 
medium (see Study II). However, it can be assumed that riboflavin contributed 
to the overall increased yield of vitamin B12 because the P. freudenreichii 
strains consumed 25-85% of the riboflavin present in the medium, while the 
A. acidipropionici strains did not(see study II). Supplementation with both 
riboflavin and nicotinamide resulted in higher production levels of vitamin B12 
than did supplementation with DMBI for seven strains (261, 262, 263, 264, 
266, 284 and 285). Unexpectedly, supplementation resulted in a decrease in 
vitamin B12 production in five strains (274, 275, 276, 282 and 286). 
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5.1.2.3 Yield of vitamin B12 corrected for growth 
Production of vitamin B12 in P. freudenreichii was previously reported as 
proportional to growth (Hargrove and Leviton, 1955; Vorobjeva, 1999c), which 
would suggest similar accumulated vitamin levels in the cells. To test this, the 
obtained amount of vitamin B12 was additionally calculated as the amount of 
vitamin accumulated per gram of wet cells (Figure 13). Thus, the vitamin B12 
levels accumulated within the cells, and the response to the supplements 
remained strain dependent. Altogether, these results revealed that the 
availability of exogenous DMBI was not limiting for B12 production under the 
conditions tested. Additionally, the lack of a response to DMBI 
supplementation by several strains could be attributed to their inability to take 
up DMBI from the medium, especially by the strains that responded to the 
supplementation with riboflavin and nicotinamide. For the other strains, the 
two-step incubation process itself may ensure sufficient production of DMBI 
in P. freudenreichii. The production capacity appears strain dependent and 
not directly dependent on growth. A. acidipropionici does not appear to 
produce DMBI and, therefore, must rely on exogenous supplementation to 
produce active vitamin B12. 
5.1.3 VITAMIN B12 PRODUCTION UNDER DIFFERENT GROWTH 
CONDITIONS AND WITHOUT SUPPLEMENTS (STUDY III) 
In study III, the capability of P. freudenreichii to produce active vitamin 
B12 was assessed in the two-step process, in two different growth media and 
without cobalt or DMBI addition. The aim was to determine whether the 
production was affected by the level of growth and the metabolic state of the 
cells. To this end, the production levels of vitamin B12 and other key 
metabolites were analysed. These analyses were complemented by an analysis 
of differential global protein production by the P. freudenreichii 2067 (257) 
strain. The samples for the analysis of metabolites were harvested at the mid-
Figure 13 Amount of vitamin B12 accumulated in the bacterial cells calculated pergram of wet cell mass. The 
strains are grouped according to their response to supplementation. *No firm cell pellet could be obtained from 
these strains, and therefore no calculation per gram of cell mass was made. 
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exponential, stationary and late stationary growth phases, while proteomes 
were analysed from the mid-exponential and stationary phases. 
5.1.3.1 Effect of growth media on the level of growth and acid 
production 
We selected two growth media for the study: PPA, a laboratory medium 
based on sodium lactate and yeast extract, that has been selected for its 
proximity to nutritional conditions of Swiss cheese (Dalmasso et al., 2012a; 
2012b) and WBM, a whey-based medium supplemented with yeast extract, 
that has often been used for industrial vitamin B12 production (Bullerman and 
Berry, 1966; Marwaha et al., 1983; Hugenschmidt et al., 2011). To determine 
the growth dynamics in the media, a growth curve that facilitated selection of 
sampling times for samples corresponding to the mid-exponential phase of 
growth was created (Figure 14). 
The growth curve revealed that the media differed markedly in their 
abilities to support the growth of P. freudenreichii 2067, with a considerably 
shorter generation time of 4.2 hours in PPA versus 5.8 hours in WBM, but with 
a much higher OD600 value of 10.3 in WBM versus 2.8 in PPA at the end of 
growth. Additionally, based on the growth curve, sampling points at the mid-
exponential phase were established at 24 hours for PPA and 30 hours for 
WBM.  
The differences in the amounts of available carbon sources in the two media 
were reflected by the acid production (Figure 15). The abundance of lactose 
resulted in much higher concentrations of propionic acid (13.8 ± 1.3) and 
acetic acid (5.4 ± 0.1 mg/mL) in WBM, which was concurrent with the pH drop 
from 6.4 to 4.6. In agreement with previous studies (Piveteau, 1999; Crow, 
1986), in WBM, P. freudenreichii 2067 fermented lactic acid prior to 
Figure 14 Growth curves used to estimate the time at which cells grown in WBM and PPA reach mid-exponential 
growth phase. The times selected as mid-exponential phase sampling points for each medium are indicated with 
arrows. 
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fermenting lactose. The presence of unused lactose (25 ± 1.5 mg/mL) in WBM 
at the end of incubation suggests that in this medium growth was inhibited by 
low pH rather than by exhaustion of carbon sources, as opposed to PPA, where 
pH increased from 6.0 to 6.2. In PPA, the starvation imposed by the limited 
amount of carbon sources-first lactic acid and then pyruvic acid- prompted 
swith to amino acid metabolism in P. freudenreichii 2067, as evidenced by the 
increased amount of acetic acid (2.9 ± 0.0 mg/mL) in proportion to the 
propionic acid (5.9 ± 0.2 mg/mL) accumulated (Crow, 1986). 
5.1.3.2 Production of active and pseudovitamin B12 
The levels of active and pseudovitamin B12 measured from the P. 
freudenreichii cells at the mid-exponential growth phase were similar in both 
media, at <20 ng/mL and <7 ng/mL, respectively (Figure 16).  
At 72 hours, the cultures were transferred to aerobic growth, and 
concurrently stationary phase samples were taken. At this time point, slightly 
higher levels of vitamin B12 (45.3 ± 1.7 ng/mL) were detected in PPA relative 
to WBM (37.9 ± 1.9 ng/mL), while the levels of pseudovitamin B12 remained 
similar in both cultures (below 40 ng/mL). At the late stationary phase, levels 
of vitamin B12 detected in WBM and PPA were 124.8 ± 34.7 ng/mL and 120 ± 
10.4 ng/mL, respectively. No pseudovitamin B12 was detected at this time 
point. It was assumed that the increased availability of oxygen allowed for the 
production of endogenous DMBI and led to apparent conversion of 
pseudovitamin B12 into the active form. The production of active vitamin 
during anaerobic incubation was attributed to the availability of residual 
oxygen in the cultures. 
Figure 15 Levels of sugars and accids accumulated in the PPA and WBM growth media during growth of P. 
freudenreichii 2067 at mid-exponential growth phase (t1), stationary phase (t2) and at the end of incubation at 
168 hours (t3). The levels detected in fresh media are also shown (FM). 
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Although the anaerobic jars ensure the removal of oxygen from the headspace 
of the culture, the oxygen that is dissolved in the medium remains. 
For the relative comparison, the amount of vitamin B12 produced in the 
cultures was recalculated as the amount of vitamin accumulated per gram of 
wet cells (Figure 17). The production of vitamin was found to be higher in PPA-
grown cells than in WBM-grown cells at each sampling point, suggesting that 
at the growth conditions tested, the vitamin B12 production is not dependent 
on growth. Conversely, the production is most likely limited by the restricted 
availability of cobalt, as the strain 2067 (257, see Table 3) grown under the 
same conditions, but with addition of cobalt, accumulated over 10-fold more 
of vitamin B12 per gram of cell mass (see figure 13).  
Figure 16 Production of cobamides measured from the cells of P. freudenreichii 2067 grown in PPA and WBM 
media. The sampling times were mid-exponential growth phase (t1), stationary phase 72h (t2) and at the end of
incubation at 168 hours (t3). No pseudovitamin B12 was observed after the switch to aeration.  
Figure 17 Production of cobamides accumulated per gram of wet cell mass. The sampling times were mid-
exponential growth phase (t1), stationary phase 72hours (t2) and at the end of incubation at 168 hours (t3). The 
lower growth in PPA resulted in higher amounts of vitamin B12 accumulated per gram of cell mass. 
Results and discussion 
38 
5.1.3.3 Global protein production 
The 2DE analysis of the global protein production during the mid-
exponential phase in PPA- and WBM-grown P. freudenreichii 2067 cells led 
to the identification of 51 gene products that were identified from 28 
differentially abundant protein spots (fold change ≥ 1.4, p< 0.05) (Table 5 and 
study III, Supplemental file 1). Among these, 12 proteins were identified as 
single hits. 
Eight of the proteins were more abundant in the PPA proteome; they 
included proteins associated with lipid metabolism (FabH, MaoC), energy 
production (AtpD, FixB), and protein production (GlnRS and MiaB1). Two 
potential oxidoreductases (the SDR and FAD-dependent pyridine nucleotide-
disulfide oxidoreductases) and a putative glutamate synthase (GLS) were also 
identified. Proteins identified as more abundant from the WBM proteome 
included oxidative stress-associated cysteine synthase (Cys2) and a superoxide 
dismutase (SodA), each identified from two separate spots. 
The analysis of the protein production during the stationary phase returned 
112 gene products from 65 differentially abundant spots (fold change ≥ 1.5, p< 
0.05), with 21 single identifications (Table 5). The more abundant proteins 
from the PPA proteome included proteins involved in energy generation 
through the metabolism of pyruvate (NifJ1, PPDK) or feeding of the TCA cycle 
(SdhA3, AspA1/2, and GLS). Also, the stress response-related proteins 
ClpATPase (ClpB2), protein synthesis-associated SerRS1 and a potential 
dehydrogenase (SDR_c) were found. The proteins identified from the WBM 
proteome included proteins associated with glycolysis/lactate utilisation (L-
LDH, GAPDH, FBA2), nitrogen metabolism (GDH), and stress (SDR, ClpB1, 
Cys2, SodA, IbpA). 
The differences in the proteomes reflected the differences in the media. For 
example, the cells grown in PPA without lipid sources had elevated levels of 
proteins involved in lipid metabolism, while the faster growth rate was 
reflected in the higher abundance of enzymes involved in protein synthesis. 
However, the abundance of lactose and resulting high acid production led to 
increased production of several stress-related proteins (ClpB1, Cys2, and 
SodA) in WBM. The switch to lactose utilisation at the later growth stages was 
reflected by the increased abundance of glycolytic proteins such as GAPDH 
and FBA2, while the increased production of two aspartate ammonia lyases 
during the stationary phase in PPA suggested a switch to amino acid 
metabolism for energy generation in response to the carbon source limitation. 
Out of over 20 vitamin B12 biosynthetic proteins, five (HemB, HemL1, 
HemL2, CbiL and CbiO) were identified from spots that were differentially 
abundant in the PPA versus WBM proteomes (see study III, Supplemental file 
1). However, neither of these proteins were detected as a single or best hit. 
Therefore, it can be assumed that under the conditions tested, the abundance 
of B12 biosynthesis proteins did not significantly differ between PPA- and 
WBM-grown cells. 
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Taken together, these results imply that P. freudenreichii is capable of 
producing active vitamin B12 regardless of the metabolic state of the cells and 
that the production is limited by the availability of cobalt. Nevertheless, the 
levels of vitamin B12 obtained are relevant from the perspective of food 
fortification. Absorption of vitamin B12 from food is mediated by the Intrinsic 
Factor, and it reaches a maximum at 1.5-2 μg per meal (EFSA NDA Panel, 
2015). With the absorption level of vitamin B12 estimated at 40% from food 
(EFSA NDA Panel, 2015), the content of vitamin B12 of 4-5 μg per food portion 
would be sufficient and is in line with the adequate intake (AI) value of 4-5 
μg/day for adults proposed by the EFSA. These levels could be reached with 
34-42 mL of the cultures with the vitamin B12 production levels obtained here.  
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5.2 GENOMICS OF P. FREUDENREICHII 
At the beginning of this study only one complete genome sequence was 
available for P. freudenreichii (Falentin et al., 2010). The most likely reason 
for this was the lack of a suitable sequencing platform. Propionibacteria have 
DNA with high GC% contents and multiple regions of repeated sequences. 
These two features mean that PCR-based sequencing is unreliable due to the 
so-called GC bias, while the platforms that produce short sequence reads 
render the genome assembly difficult, if possible at all (Lee et al., 2016). For 
this reason, in study IV, the PacBio RSII sequencing platform, in which no GC 
bias is observed and in which the long reads allow genome closing (Rhoads 
and Au, 2015) was tested on P. freudenreichii DSM 20271. In study V, 
additional 18 strains were sequenced and a comparative genomics study was 
performed on the 20 complete genomes of P. freudenreichii that are currently 
available.  
5.2.1 WHOLE GENOME SEQUENCING WITH PACBIO (STUDY IV) 
In study IV, whole genome sequencing of one of the P. freudenreichii type 
strains, P. freudenreichii subsp. freudenreichii DSM 20271 was performed. 
The sequence was generated on the PacBio RSII platform using a standard 
PacBio 10 kb library, two SMRT cells and a 180 min movie time. With the 
HGAP algorithm (Chin et al., 2013), the genome was assembled into a single, 
circular contig (Figure 18), confirming that the PacBio sequencing platform 
2,649,166 bp 
67.34 % GC 
Figure 18 Genome properties of Propionibacterium freudenreichii ssp. freudenreichii DSM 20271T . The circles
are from inner to outer order: GC skew, GC%, putative m4C, m6A, tRNA, rRNA, CDS reverse, CDS forward. CDS
are colored according to the COG functional categories 
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can overcome the high GC% content and the regions of repeated sequences in 
P. freudenreichii and showing that it is well-suited for de novo whole genome 
sequencing of the species. Following the publication of study IV, an additional 
whole genome sequence of the strain P. freudenreichii JS closed with the aid 
of the PacBio sequencing was published (Ojala et al., 2017). 
5.2.2 SEQUENCING OF 18 ADDITIONAL P. FREUDENREICHII 
STRAINS (STUDY V) 
In study V, 17 new genomes were sequenced and the type strain DSM 4902 
(JS15) was resequenced. Seven of the strains were sequenced with the use of 
P4/C2 chemistry, while for the remaining 11 the newer P5/C3 chemistry was 
used (Table 6). 
 
Table 6 Summary of the sequencing parameters used to obtain the whole genome sequences of the 18 P. 
freudenreichii strains. 
Strain 
name 
Sequencing 
Chemistry 
SMRT
cells 
Movie 
Time (min) 
Total 
Number of 
Subreads 
Total Number 
of Bases 
Mean 
Subread 
Length (bp) 
N50 
Subread 
Length (bp) 
JS4 P4/C2 2 120 142,306 465,129,578 3,268 4,131 
JS10 P4/C2 2 120 205,113 606,802,054 2,958 3,733 
JS15 P4/C2 2 120 179,642 540,206,310 3,007 3,653 
JS18 P4/C2 2 120 194,246 550,199,736 2,832 3,679 
JS20 P4/C2 2 120 230,371 632,635,668 2,746 3,456 
JS22 P4/C2 2 120 181,361 563,541,807 4,090 3,107 
JS23 P4/C2 2 120 192,373 617,310,336 3208 4,222 
JS2 P5/C3 2 240 100,864 719,516,424 7,133 8,940 
JS7 P5/C3 2 240 107,194 1,002,978,417 9,356 13,043 
JS8 P5/C3 2 240 139,418 1,149,552,255 8,245 11,148 
JS9 P5/C3 2 240 160,808 1,316,084,462 8,184 11,023 
JS11 P5/C3 2 240 184,744 1,422,323,823 7,698 10,498 
JS12 P5/C3 2 240 207,391 1,490,421,212 7,186 9,765 
JS13 P5/C3 2 240 103,466 793,823,369 7,672 10,156 
JS14 P5/C3 2 240 125,130 966,521,587 7,724 10,326 
JS17 P5/C3 2 240 151,002 1,149,295,071 7,611 10,232 
JS21 P5/C3 2 240 173,843 1,298,367,718 7,468 9,906 
JS25 P5/C3 2 240 192,104 1,293,994,542 6,735 8,805 
 
The newer chemistry allowed for an extended sequencing movie time, 
increased mean read length and a higher total of sequenced bases. Overall, it 
resulted in a deeper genome coverage (Table 7). Nevertheless, both 
chemistries allowed for the assembly of the genomes into single, circular 
contigs. 
Assembly of the sequencing data obtained from the 18 strains resulted in 
31 circular sequences. Eight of the strains had two complete chromosomes, 
which stemmed from duplication and relocation of transposable elements 
(Table 8). 
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Table 7 The P. freudenreichii strains included in study V. Table shows the summary of the 31 genomes sequenced 
in this study from 18 strains as well as the genomes of the 2 previously sequenced strains JS and DSM 20271. In 
case of the strains with two bacterial genomes, the sequences used for the comparative genomics are marked with 
asterisk. 
 
Interestingly, the transposases did not appear to be acquired through 
horizontal gene transfer, as each of them was present in their respective 
genomes in at least one additional location. Moreover, all of these transposases 
had counterparts in multiple strains, suggesting their intrinsic character in the 
species and implying a role in the adaptation strategies. 
Strain 
name 
Sequence 
name 
Accession 
number 
Genome 
size (bp) 
Genome 
coverage 
GC% No. of 
predicted 
genes 
Note 
JS PFREUDJS001 LN997841.1 2 675 045 691 67%% 2 382 Sequenced previously (Ojala 
et al. 2017) 
JS2 PFRJS2 LT576032 2 655 351 317 67% 2 310  
JS4 PFRJS4 LT576033 2 654 663 158 67% 2 366  
JS7 PFRJS7-1* LT618776 2 738 418 300 67% 2 412  
  PFRJS7-2 LT618777 2 700 482 50 67% 2 355  
  PFRJS7-PH LT618778* 37 936 60 65% 59  Phage genome 
JS8 PFRJS8 LT576042 2 655 373 392 67% 2 324  
JS9 PFRJS9-1* LT618785 2 720 049 219 67% 2 405  
  PFRJS9-2 LT618786 2 718 592 219 67% 2 401   
JS10 PFRJS10 LT576035 2 626 110 208 67% 2 329   
JS11 PFRJS11 LT576038 2 537 402 501 67% 2 200   
JS12 PFRJS12-1* LT604998 2 615 181 250 67% 2 275  
  PFRJS12-2 LT576787 2 613 734 250 67% 2 274   
  PFRJS12-3 LT604882** 24 909 400 64% 32 Putative conjugtive plasmid 
JS13 PFRJS13-1* LT618779 2 537 370 210 67% 2 201  
  PFRJS13-2 LT618780 2 520 651 90 67% 2 189   
JS14 PFRJS14 LT593929 2 507 188 330 67% 2 180   
JS15 PFRJS15-1* LT618787 2 621 081 94 67% 2 322  
  PFRJS15-2 LT618788 2 616 005 94 67% 2 320  
JS16 RM25 NZ_CP010341.1 2 649 163 190 67% 2 321 Sequenced previously 
(Koskinen et al. 2015) 
JS17 PFRJS17-1* LT618789 2 755 516 192 67% 2 455  
  PFRJS17-2 LT618790 2 754 069 192 67% 2 454   
JS18 PFRJS18 LT576034 2 661 974 190 67% 2 358   
JS20 PFRJS20-1* LT618791 2 678 207 106 67% 2 376   
  PFRJS20-2 LT618792 2 682 327 106 67% 2384  
JS21 PFRJS21-1* LT618781 2 659 993 222 67% 2 330  
  PFRJS21-2 LT618782 2 658 550 222 67% 2 329   
JS22 PFRJS22-1 LT599498 2 633 661 190 67% 2 326  
  PFRJS22-PH LT615138* 39 309 102 66% 61 Phage genome 
JS23 PFRJS-23-PH LT618794 42 723 25 65% 66  
  PFRJS-23 LT618793* 2 630 698 210 67% 2 335 Phage genome 
JS25 PFRJS25-1 LT618783 2 666 517 400 67% 2 336   
  PFRJS25-2 LT618784** 35 640 800 64% 46 Putative conjugative plasmid 
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The two genomes of the strain JS13 differed by 12 genes that were 
organised into a gene cluster. Aside from 4 transposases, the gene cluster 
consisted of eight hypothetical proteins, one with similarity to Helicase 
conserved C-terminal domain (PF00271.25). It was unclear whether the 
presence/absence of the cluster resulted from an insertion or deletion, but an 
identical gene cluster was found in one additional strain, JS11, in 100% of the 
genome sequences.  
Three of the sequences were presumably mobilised prophages, as their 
chromosomal counterparts were also found. The strain JS7 was the only 
phage-carrying strain that also had a genome from which the phage was 
absent. Two additional sequences were classified as putative conjugative 
plasmids, carried by the strains JS12 and JS25. 
A large duplication was detected in the genome of the JS17 strain. The 
duplication appeared transposase-mediated and spanned 35 genes: 
PFR_JS17-1_676 to PFR_JS17-1_710 and PFR_JS17-1_711 to PFR_JS17-
1_745, located between an Uma4-type transposase and an aspartate ammonia 
lyase. In order to eliminate the possibility of an assembly error, the edges of 
the duplication by PCR were analysed. The duplication region included genes 
coding for, among others, thiamine biosynthetic proteins, transporters and 
glycerol metabolism proteins. Most notably, the duplication led to the 
presence of three copies of aspartate ammonia lyase instead of the usual two 
copies for P. freudenreichii, which could result in increased aspartase activity 
in the JS17 strain. The activity of aspartate ammonia lyase is associated with 
gas production and formation of desirable eyes in cheeses. However, it can 
lead to excessive gas production and result in a split defect (Daly et al., 2010). 
5.2.2.1 Evaluation of re-sequencing of the strain DSM 4902 
The suitability of the sequencing method can be assessed by comparing the 
sequencing outcome with a sequence obtained through a high-confidence 
method such as Roche 454 or Sanger (Chin et al., 2013; Koren et al., 2013). 
Therefore, the complete genome sequence for the strain ATCC9614 
(FN806773.1), which was obtained through Sanger sequencing (ABI3730 
sequencer) and assembled with primer walking (Falentin et al., 2010) was 
compared with the PacBio-sequenced version, strain Js15 (LT6187879) 
(Figure 19). The BLASTn search revealed 99% identity over 99% of the 
Figure 19 Progressive Mauve alignment of the two genome sequences of the strain P. freudenreichii DSM 4902, 
the one generated with PacBio platform (LT6187879) and with Sanger sequencing (FN806773.1). The numbered 
features correspond to regions of sequences missing from the other version of the genome. The resulting “gaps” 
are listed in Table 9. 
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sequence. The Progressive Mauve alignment of the genomes allowed an 
analysis of the differences between the genomes by revealing the gaps and 
single-nucleotide polymorphisms (SNPs).  
 
Table 9 Summary of the gaps between the two versions of the genome sequences of the strain P. freudenreichii 
DSM 4902.  
Feature 
on the 
alignment
Genome Position in 
the 
genome 
Gap 
length 
Position in 
the other 
genome 
Locus ID in the other 
genome 
Annotation 
1 FN806773.1 351844 820 351604 PFR_JS15-1_292 Transposase for insertion 
sequence element 
2 FN806773.1 1008180 3195 1008757 PFR_JS15-1_878 Uma4 protein 
3 FN806773.1 1953026 1433 1955599 PFR_JS15-1_1737 Transposase of ISAar20, ISL3 
family 
4 FN806773.1 2311186 1707 2315190 PFR_JS15-1_2045 Transposase of ISAar20, ISL3 
family 
5 LT618787 1795117 1254 1791345 PFREUD_24740, 
PFREUD_24750 
2 transposases, repeat region 
6 LT618787 2579351 1255 2573640 PFREUD_25150, 
PFREUD_25160 
2 transposases, repeat region 
 
The analysis suggests that the major differences lay in the presence and 
locations of different transposases in each of the genomes (Table 9), while the 
minor differences, not visible on the alignment, were attributable to the nine 
identified SNPs (Table 10). The observed differences can be a result of the 
origins of the strains, which although equivalent, were obtained from different 
strain collections. This comparison confirms that both sequencing methods 
are suitable for whole genome sequencing of P. freudenreichii.  
 
Table 10 Summary of the SNPs between the two genome sequences of the strain DSM 4902 
 
5.2.3 COMPARATIVE GENOMICS 
The newly sequenced genomes and the two previously published sequences 
for strains JS16 (study IV, Koskinen et al., 2015) and JS (Ojala et al., 2017) 
were subjected to a comparative genomics analysis.  
SNP pattern Position in the genome 
LT618787 Position in the genome FN806773.1 
cg 37260 37500 
ca 107572 107812 
ct 1488990 1485221 
ga 1503537 1499768 
ac 1656803 1653033 
ga 1774109 1770339 
ga 1788218 1784448 
ct 1970134 1966130 
cg 2242225 2238221 
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5.2.3.1 Genome organization and average nucleotide identity 
The ANI calculated through pairwise BLAST alignments (Richer and 
Rosselló-Móra 2009) revealed that the genomes of the P. freudenreichii 
strains were highly collinear, with an ANI value of 97.96% between strains JS7 
and JS9 and 100% between strains JS11 and JS13 (Figure 20A). Based on the 
ANI values, strains JS4, JS15 and JS17 were on average the most similar to all 
Figure 20. Genome composition and organisation. Panel A) Average Nucleotide Identity (%) calculated based on 
pairwise BLAST alignment (ANIb). The levels of similarity are highlighted by coloring from green for the most 
similar to red for the most dissimilar; Panel B) Whole genome alignments generated with ProgressiveMauve. The 
genomes are arranged according to the phylogenetic tree generated from core genome alignments (see “Core and 
pangenome analyses”). 
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other strains, while strains JS9 and JS20 were the most dissimilar to all other 
strains, while they were slightly more similar to one another.  
The strains of cereal origin (JS11-JS14) were more similar to each other 
than to other strains. The whole genome alignments with Progressive Mauve 
showed that despite genome-wide collinearity, large regions of inversions and 
other types of reorganisations were present, even among closely related 
strains. Such reorganisations were observed most clearly between strains JS 
and JS10, JS15 and JS23, and JS4 and JS21 (Figure 20B). These genome 
reorganisations appear to be transposase-mediated, as transposases are found 
on the edges of several of the locally collinear blocks. It is noteworthy that both 
strain types (JS15 and JS16) show a markedly different genome organisation 
from the other strains, possibly because of adaptation to the extended 
exposure to laboratory conditions. 
5.2.3.2 Core genome and pangenome analyses 
For the estimation of the core genome and pan-genome, one genome from 
each strain was re-annotated with PROKKA and analysed with the Roary 
pipeline (Page et al., 2015). The analysis revealed 4606 orthologue groups out 
of which 1636 belonged to the core genome. The number of orthologue groups 
in accessory genomes varied between 530 in strain JS12 to 787 in strain JS17. 
The strain JS20 had the highest number of unigue genes (160), followed by 
strains JS7 (135), JS12 (129), JS17 (118) and JS9 (116). The strains JS11 and 
JS13 have one and no unique genes, respectively, due to the fact that the 
strains are largely identical. In addition to the 12 genes missing from part of 
the genome sequences of the strain JS13, the differences between those strains 
include: the gene PFR_JS11_1775 coding for Peptidase dimerization domain 
protein is split into two in strain JS13 (PFR_JS13-1_1775 and PFR_JS13-
1_1776), the gene PFR_JS13-1_1785 coding for Hypothetical protein is 
missing from the JS11 strain, while the gene PFR_JS11_2200 coding for 
Hypothetical protein is missing from the strain JS13. The numbers of 
orthologues belonging to the accessory genome of each strain as well as unique 
genes are shown in Figure 21.  
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Figure 21 Panel A) An unrooted phylogenetic tree constructed on the basis of core genome alignments; Panel B)
Flower plot representing comparative analysis of the genomes. The number of orthologues in the accessory genome
of each strain are indicated on the petals. The number of orthologues unique to the strain is indicated in brackets. 
The petals are coloured based on the phylogenetic grouping of the strains. 
 *Type strain P. freudenreichii DSM 20271; **Type strain P. freudenreichii DSM 4902  
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5.2.4 BIOINFORMATICS ANALYSES 
The genomes were analysed further with multiple bioinformatics tools, 
allowing for more in-depth characterisation of individual strains. This 
approach was used to identify the mobile elements, including bacteriophages, 
plasmids and genomic islands. Then, the strains’ immunity to mobile 
elements, namely the CRISPR-Cas systems as well as restriction-modification 
(RM) systems were explored.  
5.2.4.1 Bacteriophages 
Relatively little is known about bacteriophages that infect P. freudenreichii. 
Currently, only ten complete bacteriophage genome sequences are available: 
one filamentous phage (B5), and nine tailed phages (B3, B22, E1, E6, G4,  
Doucette and Anatole (Modlin et al., unpublished) and PFR1 and PFR2 
(Brown et al., 2016). In the current study, three additional bacteriophage 
genomes were detected as a circular DNA within strains JS7, JS22 and JS23 
(PJS7, PJS22 and PJS23) (see Table 7). The phage found in the strain JS7 
(LT618778) had the total genome size of 37936 bp and 59 predicted open 
reading frames. When integrated into the chromosome as a prophage, it was 
located between the coding sequence for transcriptional regulator KmtR, 
located immediately downstream of a tRNA-Ala(agc) and a tRNA-Lys(ttt), 
located immediately upstream of the transcriptional regulator MtrR. A BLAST 
search against the known Propionibacteria phages showed that PJS7 was 99% 
identical with the 38071-bp-long PFR1 phage (NC_031076.1). The difference 
could be found in the gene that coded for the minor tail protein, where PFR-
JS7_47 was 135 nucleotides shorter than the gene coding for BI042_gp13 of 
the PFR1 phage.  
Strain JS7 differed from the other two phage-carrying strains by the 
additional presence of a bacterial genome that was cleared of a prophage 
(LT618777). Replication of the circular phage genome in JS7 was followed by 
PCR after subculturing, which revealed the successive integration of the phage 
genome at the same locus after five passages in the PPA medium (Table 11).  
The other two strains, JS22 and JS23 carried the prophage on all of the 
copies of the chromosome. Phages PJS22 and PJS23 were 97% identical over 
68% of their sequences. PJS22 showed 99% identity over 81% of the sequence 
to previously sequenced phage B22 (KX620750.1). PJS23 was the most similar 
to phage Doucette (KX620751.1) with 97% identity over 64% of the sequence. 
The PJS22 phage was inserted between the sequence coding for tRNA-Gly(ccc) 
and a gene encoding DNA protection during starvation protein 2 (PFR_JS22-
1_1997), while the PJS23 prophage was inserted between tRNA-Pro(tgg) and 
a gene encoding Quaternary ammonium compound-resistance protein SugE 
(PFR_JS23_1469). 
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Table 11 Phage PJS7 integration study based in PCRs. The fresh reactions were performed at 4 days in three 
independent experiments from colonies picked randomly from PPA agar plate started directly from glycerol stock. 
The reactions of propagated cells were performed at 7 days, on cells from colonies generated by re-streaking of 
the previously tested colony on a new PPA agar plate. All three types of reactions were performed on the cells 
from the same colony. Presence of all three types of genomes in each colony is consistent with the results of the 
sequencing study. After 5 generations, the circular phage is no longer observed, while genomes with integrated 
phage and with no phage at all are present in nearly all tested colonies. 
Experiment Genome without 
phage 
Genome with 
phage 
Circular 
phage 
Fresh        
I 6/6 5/6 5/6 
II 7/8 7/8 8/8 
III 8/8 8/8 4/8 
Propagated       
1st generation 1/8 8/8 7/8 
5th generation 8/8 8/8 0/8 
10th generation 7/8 8/8 0/8 
 
 
All of the bacterial genomes were checked for additional prophage 
sequences with two dedicated programs: Phaster and Prophinder. From the 
candidate prophages, only the prophage identified from strain JS17 appeared 
complete. The prophage JS17 was located between the tRNA-Ser(tga) gene and 
a transposase (PFR_JS17-1_2095). A BLAST search revealed 96% identity 
over 61% and 64% of the sequence to Propionibacterium phages Doucette and 
G4, respectively. Similarly, a BLAST search against phages PJS22 and PJS23 
showed 97% identity over 62% and 65% of the sequence, respectively. 
Based on sequence similarity, the sequenced P. freudenreichii phages can 
be divided into three groups. Group 1 consisted of B22 (KX620750), Doucette 
(KX620751), E6 (KX620753), G4 (KX620754), Anatole (KX620748), B3 
(KX620749), E1 (KX620752), PJS22, PJS23 and the prophage of strain JS17. 
Group 2 consisted of phages PFR1 (KU984979), PFR2 (KU984980) and PJS7. 
The one-member Group 3 consisted of the filamentous phage B5 (AF428260), 
which had a stronger resemblance with the phages that infected Gram-
negative bacteria (Chopin et al., 2002) (Figure 22). 
Transposases were found in the prophage sequence of strain JS17 and the 
bacteriophage PJS23. The transposases PFR_JS17-1_2038 and PFR_JS17-
1_2067 were both identical to eight (PFR_JS17-1_341, PFR_JS17-1_394, 
PFR_JS17-1_676, PFR_JS17-1_711, PFR_JS17-1_2205, PFR_JS17-1_2341, 
PFR_JS17-1_2347 and PFR_JS17-1_2416) and six other transposases 
(PFR_JS17-1_13, PFR_JS17-1_46, PFR_JS17-1_72, PFR_JS17-1_657, 
PFR_JS17-1_658 and PFR_JS17-1_1466) found in the same strain, 
respectively. Additionally, the transposases PFR_JS17-1_657 and PFR_JS17-
1_658 were observed as duplicated in part of the genome sequences of strain 
JS17. These transposases were identical to the transposases found in part of 
the genome sequences of strains JS12 and JS15 (see Table 8). In phage PJS23, 
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there were four transposase-like elements, PH1_40-PH1_43, co-located on 
the phage genome (corresponding to PFR_JS23_1432 -PFR_JS23_1435 on 
the bacterial chromosome). The transposases PFR_JS23_1432 and 
PFR_JS23_1435 were both found only in the phage region of the genome, 
while PFR_JS23_1433 (integrase) and PFR_JS23_1434 (transposase) were 
each found in two additional, co-located copies (PFR_JS23_368 and 
PFR_JS23_369; PFR_JS23_2185 and PFR_JS23_2184). The transposase 
pair located on the PJS23 phage genome appeared to be disrupting 
transposases PFR_JS23_1432 and PFR_JS23_1435. This could mean that the 
insertion of the new mobile element, intrinsic to the strain, serves as a strategy 
for better control of the phage and further supports the role of P. 
freudenreichii transposases in the adaptation to a changing environment. 
 Lysogeny was previously described in P. freudenreichii (Herve et al., 
2001). However, this is the first study to show P. freudenreichii-infecting 
bacteriophages as complete prophages and as free, circular genomes. The 
1 
2 
3 
Figure 22 Progressive Mauve genome alignments of all of the sequenced bacteriophages infecting
Propionibacterium freudenreichii. Phages form 3 distinct groups. Group: 1 G4, B22, Doucette, E6, Anatole, B3, 
E1, PJS22, PJS23; Group2: PFR1, PFR1, PJS7; Group 3: filamenous phage B5. 
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recent report of the bacteriophage PFR1, which shares 99% sequence identity 
with the PJS7 phage reported here, demonstrated the phage’s ability to enter 
the lytic cycle and its ability to infect a strain of Cutibacterium acnes (Brown 
et al., 2016). Further studies are needed to establish the dynamics of the 
relationships between the P. freudenreichii strains and the bacteriophages 
that can infect them.  
5.2.4.2 Plasmid-like elements 
Owing to the whole genome sequencing from the long reads, two additional 
circular elements, PFRJS12-3 (LT604882) and PFRJS25-1 (LT618784), were 
discovered in P. freudenreichii strains JS12 and JS25. These elements were of 
24.9 kbp and 35.6 kbp in size and encoding 32 and 46 predicted open reading 
frames, respectively (Figure 23). A BLASTn search revealed that there was no 
significant similarity between either the previously sequenced plasmids of 
P. freudenreichii (Perez-Chaia et al., 1988; Rehberger and Glatz 1990; Dasen 
1998; Kiatpapan et al., 2000; Jore et al., 2001; Stierli 2002), which included 
p545 (AF291751.1), pRGO1 (NC_002611.1), pLME106 (NC_005705.1) and 
pLME108 (NC_010065.1), or the C. acnes plasmids, which included 
HL096PA1 (CP003294.1) (Kasimatis et al., 2013) and PA_15_1_R1 
(CP012356.1). A BLASTn search of the JS12 plasmid-like element revealed 
that the gene encoding transposase located at position 8594-9669 had 95% 
identity to the transposase genes from P. freudenreichii, A. acidipropionici, 
and Micrococcus luteus and 93% identity to the transposase gene from 
Corynebacterium variabile. The transposase at position 5799-7130 had 90% 
sequence identity to A. acidipropionici and M. luteus, and the transposase at 
position 12361-12930 had 92% identity to resolvase-encoding genes from A. 
acidipropionici. A BLASTn search of the JS25 plasmid-like element revealed 
88% identity to the Propionibacterium phage PFR1 over the stretch of its 
PFR1_23, PFR1_24 and PFR1_25 genes that encoded three hypothetical 
proteins. Additionally, the 5’ end of the sequence showed 98% identity with a 
47-nt stretch of the sequence in the non-coding region from Burkholderia 
pyrrocinia strain DSM 10685 plasmid p2327 and the Burkholderia 
cenocepacia J2315 pBCJ2315 plasmid. A BLASTp search against these 
plasmid sequences showed a negligible sequence similarity. 
Further analysis showed that the JS25 sequence was 99% identical over 
31% of the sequence of JS12 (Figure 23). The analysis against the Conserved 
Domains Database (CDD) (Marchler-Bauer et al., 2017) revealed multiple 
regions of similarity to conjugative plasmids shared between the elements. 
These regions of similarity included genes coding for the following: a conjugal 
transfer protein with conserved domains for TrwC relaxase and a TraA 
exonuclease, which assist in preparing the plasmid DNA for conjugal transfer; 
TraM, a recognition site for TraD and TraG, which are proteins thought to 
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mediate interactions between the DNA-processing (Dtr) and the mating pair 
formation (Mpf) systems; a putative plasmid partition protein, ParA. Based on 
the presence of these functional genes, the elements could be considered 
conjugative plasmids. However, it remains to be elucidated whether the 
circular elements found in strains JS12 and JS25 are plasmids as no 
characteristic replication origin loci were found. Nevertheless, the presence of 
transposases with high sequence identity to other known Actinobacteria could 
mean that these elements are widespread and interchanging among the 
phylum. 
It is noteworthy that the JS25 plasmid-like element appears to be 
widespread at least among the P. freudenreichii strains (Figure 24), because a 
Figure 23 Putative conjugative plasmids identified in study V. The annotations are derived from Conserved 
Domains database. The Restriction endonuclease and Methylstransferase marked with asterisk belong to type II 
restriction-modification system identified in this work. 
Figure 24 Contigs with 99% identity over 90% of the nucleotide sequence of the JS25 plasmid-like structure in the 
P. freudenreichii strains ITG P20 (CIRM-BIA 129) (NZ_HG975461* and CCBE010000014**), ITG P1 
(CCYV01000031), CIRM-BIA 135 (CCYZ01000006) and CIRM-BIA 1025 (NZ_CCYV01000031). 
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comparison with the recently published draft genomes (Falentin et al., 2016; 
Loux et al., 2015) revealed the presence of sequences with 99% identity over 
the entire nucleotide sequence in the contigs in P. freudenreichii strains ITG 
P20 (CIRM-BIA 129), ITG P1, CIRM-BIA 135 and CIRM-BIA 1025, 
constituting 90% of the sequence of the putative plasmid. Because of the 
limited size of the contigs, it is impossible to determine whether the elements 
were circular or existed as a part of the chromosome in these strains.  
We explored the possibility that the circular elements are types of 
Integrative and Conjugal Elements (ICEs), which are widely distributed 
mobile genetic elements. ICEs differ from plasmids by their usual existence 
within the host’s chromosome, but under certain conditions, they can become 
activated, excise from the chromosome and transfer to a new recipient 
(Delavat et al., 2016). Although no such elements have been described in 
Propionibacteria to date, they are widespread among other Actinobacteria as 
two types. The FtsK/SpoIIIE-type relies on a single FtsK/SpoIIIE-like protein 
for DNA translocation, while the T4SS-type requires the assembly of a complex 
type IV translocation system for mobility (Ghinet et al., 2011). Elements that 
share structural similarities indicative of type T4SS ICEs (Tra and TrwC) are 
present in putative plasmids pJS12 and pJS25 and are also found in the 
chromosomes of strains JS7, JS9, JS12, JS18 and JS20. It is therefore possible 
that the observed plasmid-like elements are mobilised ICEs type T4SS. 
However, further studies are necessary to determine their true nature.  
5.2.4.3 Genomic islands 
The genomes were assessed for the presence of genomic islands using 
IslandViewer 3 (Dhillon et al., 2015), an integrative online tool that performs 
the analysis with three independent genomic island prediction methods: 
IslandPick, IslandPath-DIMOB, and SIGI-HMM.  
The ability to utilise lactose, a historically important trait in P. 
freudenreichii, has been previously tied to a genomic island in which genes 
coding for UDP-glucose 4-epimerase (galE1), Sodium galactoside symporter 
(galP) and Beta-galactosidase (lacZ) are located (Falentin et al., 2010). In the 
current study, the same island was found in nine other strains: JS, JS2, JS7, 
JS8, JS10, JS17, JS18, JS22 and JS23, with JS23 possessing two copies of the 
region (PFR_JS23_160-PFR_JS23_162 and PFR_JS23_2069 -
PFR_JS23_2071). Another feature, which is potentially important from the 
perspective of the dairy industry, is the ability to degrade D-lactate. Eight 
strains, including JS2, JS7, JS8, JS10, JS15, JS17, JS20 and JS23 had a D-
lactate dehydrogenase located on a genomic island, while D-lactate 
dehydrogenase in strain JS18 was located just downstream of a predicted 
genomic island. In strain JS4, a genomic island with an alternative pathway 
for the biosynthesis of rhamnose was found. It consisted of dTDP-4-
dehydrorhamnose reductase (rmlD), putative dTDP-4-dehydrorhamnose 3,5-
epimerase (rfbC) and dTDP-glucose 4,6-dehydratase (rmlB). In strains JS, 
JS2, JS4, JS10, JS17, JS18 and JS23, an island with two S-layer protein A genes 
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was identified. Finally, an island where genes encoded pilus components was 
found in strain JS18, including Sortase SrtC1 (PFR_J18_2247), Type-2 
fimbrial major subunit (PFR_J18_2248) and a Surface-anchored fimbrial 
subunit (PFR_J18_2249). 
The genomes were surveyed for known antibiotic resistance genes, and as 
previously reported (Thierry et al., 2011), in most cases these genes were not 
located on a predicted genomic island. However, strain JS8 appeared to be 
diverging from the group, as the genomic island unique for this strain included 
three genes that encoded putative antibiotic resistance related proteins: 
mitomycin radical oxidase (PFR_JS8_1331), tetracycline repressor domain-
containing protein (PFR_JS8_1332), and the puromycin resistance protein 
Pur8 (PFR_JS8_1333). Furthermore, the edges of the island were flanked by 
the gene coding for hypothetical proteins that have 98 and 99% sequence 
identity to genes from Brevibacterium linens strain SMQ-1335 that encode 
mobile element proteins.  
Additional examples include an island with genes coding for a CASCADE-
like CRISPR-Cas system in strains JS2, JS7 and JS9 (see below), an island 
encoding multiple heat-shock proteins in strains JS9 and JS20, multiple RM 
systems (see below) and the previously mentioned ICE-like elements in strains 
JS7, JS9, JS12, JS18 and JS20.  
5.2.4.4 CRISPR-Cas systems 
The CRISPR together with Cas proteins, commonly known as CRISPR-Cas 
systems, form the adaptive immunity systems that protect their hosts against 
invasion by foreign DNA. The function of the adaptive immunity system can 
be divided into two phenomena: the CRISPR adaptation and CRISPR 
interference. The CRISPR adaptation results from spacer acquisition upon 
exposure to invading DNA, while the CRISPR interference involves 
recognition of the specific spacers on foreign DNA, which in turn allows for the 
introduction of breaks into those regions of DNA and its resulting destruction 
(reviewed by Savitskaya et al., 2016). Currently, the CRISPR-Cas systems are 
subdivided into two classes, five types, and 16 subtypes. The P. freudenreichii 
genomes were analysed with a CRISPR identifying tool, CRISPR-finder. The 
identified CRISPRs are summarised in Table 12. 
After the CRISPR arrays were identified, their vicinities were checked for 
the presence of the Cas genes. Following the current classification, two types 
of CRISPR-Cas systems in P. freudenreichii were identified, both categorized 
as class 1, type I CRISPR-Cas systems based on the presence of the typical Cas3 
protein (Savitskaya et al., 2016) (Figure 25).  
The first system, with the GGATCACCCCCGCGTATGCGGGGAGAAC 
direct repeat consensus sequence, may be classified as subtype IE based on the 
sequence homology and gene organisation corresponding to the CASCADE 
system, which is well-characterised in E. coli (Jore et al., 2011; Koonin and 
Makarova 2013; Wiedenheft et al., 2011). The second system, with the 
ATTGCCCCTCCTTCTGGAGGGGCCCTTCATTGAGGC direct repeat 
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consensus sequence bears similarity to the subtype IU (previously IC) (Koonin 
and Makarova 2013). This classification is strengthened by the presence of the 
Cas4/Cas1 fusion protein that is found in several variants of the subtype IU 
(Makarova et al., 2011; Makarova et al., 2015). However, the atypical gene 
organisation suggests that it is a new variant of the subtype IU. 
The CRISPR-Cas system IE was found in strains JS2, JS9 and JS7 and 
carried 96, 65 and 105 spacers, respectively (Table 12). These systems were 
located on genomic islands in all strains, suggesting a relatively recent 
acquisition. However, a lack of sequence identity between the spacers suggests 
an independent acquisition of immunity (adaptation) in each strain. The 
CRISPR-Cas system of strain JS7 has a transposase inserted between the cse1 
and cse2 genes and only a fragment of the cas2 gene comprising a part of a 
larger hypothetical protein (Figure 25). In strain JS9, the first 9 CRISPR 
spacers are separated from the subsequent 96 spacers by an integrase gene. A 
BLAST search of the spacers indicated immunity to all of the sequenced phages 
that infect P. freudenreichii, except for the filamentous phage B5 for which 
immunity was found only in strain JS9. Additionally, strain JS2 carried 
immunity against all three phages found in this study and to the putative 
plasmid pJS25. Strain JS7 carried immunity to putative plasmid pJS12, phage 
PJS22 and to the phage by which it was infected, suggesting that the presence 
of either the transposase or the incomplete cas2 gene may have resulted in the 
inactivity of the CRISPR-Cas system in this strain. JS9 carried markers of 
immunity against all the three phages found in this study and to the pJS25 on 
the CRISPR_2 array. 
The CRISPR-Cas system IU is more widespread in P. freudenreichii, and 
its presence has been previously reported in P. freudenreichii strains JS and 
JS15 (Falentin et al., 2010; Ojala et al., 2017). However, no classification was 
attempted then. In the current study, the IU system was found in 13 of the 
strains, including only one strain of cereal origin: JS12. In strains JS4, JS16, 
JS20, JS21 and JS25 the systems were located on genomic islands. In strains 
JS11, JS13, JS14, JS18 and JS22 no complete CRISPR-Cas systems were found, 
although strain JS22 had a short array of CRISPR. No immunity to known 
phages was found on that array. The number of spacers in IC CRISPR-Cas 
systems ranged from 25 in strain JS2 to 64 in strain JS17. 
The spacers of the strains JS and JS10 and of strains JS4, JS20, JS21 and 
JS25 were for the most part identical, which is consistent with their 
phylogenetic relatedness. In other strains, few spacers were identical, 
suggesting early diversification. Only strain JS2 carried both types of the 
CRISPR systems, although strain JS9 possessed an additional stretch of 83 
spacers separated by a distinct repeat sequence 
(GGGCTCACCCCCGCATATGCGGGGAGCAC), indicating they belonged to a 
separate CRISPR-Cas system. Nevertheless, the lack of Cas genes in the 
vicinity and location of the CRISPR array on the genomic island may mean 
that the system was acquired in an incomplete form through horizontal gene 
transfer.  
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For each of the strains, 2-4 additional “Possible CRISPRs” were identified, 
most of which mapped within the sequences coding for DNA topoisomerase 1, 
a hypothetical protein, or fell between coding sequences. None of them showed 
homology to known Cas genes. Nevertheless, the “Possible CRISPR1” from 
strain JS14, located within a hypothetical protein coding sequence 
(PFR_JS14_1397), carried a spacer with 100% identity to a fragment of the 
gene coding for a tape measure protein in phages Anatole and E1. The 
significance of this finding remains to be elucidated. 
5.2.4.5 Restriction-modification systems  
Very little is known about RM systems in P. freudenreichii. It has been 
shown that such systems are present in P. freudenreichii based on the 
observed interference with transformation efficiencies (Jore et al. 2001) and 
the host range that is dependent on the compatibility of the RM systems 
between the sources and the intended hosts of the plasmids (Kiatpapan et al. 
2000). The use of the PacBio sequencing platform allows identification of 
methylation patterns, which in turn permits identification of the recognition 
motifs of the methylases responsible (Flusberg et al., 2010). The recognition 
motifs were therefore reported for both strains sequenced with PacBio 
platform, JS and JS16 (Study IV, Koskinen et al., 2015; Ojala et al., 2017), but 
the RM systems were not previously characterised. 
To gain insight into the possible RM systems present in the 20 strains studied 
here, the genome sequences were first analysed for the presence of genes that 
could be identified as components of RM systems. As a result, 216 different 
RM system genes associated with 127 different systems were identified. The 
methylases were then assigned to motifs identified by PacBio sequencing. Of 
the 54 motifs identified, 48 were unambiguously matched to the responsible 
methylases (Table 13). Among the strains, JS2 and JS7 had three Type I 
systems, while six strains (JS8, JS9, JS11, JS13, JS14 and JS20) had two such 
systems and nine strains had a single system. In all of these strains, except 
JS10, the gene responsible for restriction was intact and the level of 
methylation was close to complete, suggesting that the systems were active as 
RM systems.  
In addition to the Type I systems, examples of Type II methylases were 
found in twelve of the strains, including systems with the same specificity in 
several strains, for instance seven strains contained a methylase recognizing 
CCWGG motif. One of the Type II systems with the recognition sequence 
CTCGAG was found on the putative plasmid, pJS12. One Type III RM system, 
with the unique recognition sequence AGCAGY, was found in five of the strains 
(JS, JS15, JS17, JS22 and JS23). Overall, the most striking feature of the RM 
systems distributed among these strains was the variability of systems and 
genomic locations found from one strain to another. This is in contrast to the 
more usual situation where at the very least there are one or more common 
methylases found in all strains of a particular species (see REBASE, Roberts et 
al., 2015). 
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Table 13 Methylation motifs and the responsible methylases identified in P. freudenreichii. Recognition sequences 
in parentheses indicates the methylase responsible cannot be assigned unambiguously. Modified bases are marked 
in gray; “not annotated” indicates there is no locus_tag as the gene is not annotated in the GenBank file. 
Organism  locus Enzyme  Recognition sequence  Type 
 P. freudenreichii JS 921 M.PfrJS1II  AGTNNNNNNCTT  I 
 566 M.PfrJS1I  AGCAGY  III 
P. freudenreichii JS2  PFR_JS2_249 M.PfrJS2I  ATCNNNNNGTCG  I 
 PFR_JS2_1297 M.PfrJS2II  AGTNNNNNNCTT  I 
 PFR_JS2_2113 M.PfrJS2III  GATNNNNNNTTT  I 
 PFR_JS2_2250 M.PfrJS2V  GCCGGC  II 
  PFR_JS2_1977 PfrJS2IV  CTTCNAC    
P. freudenreichii JS4  no hits       
P. freudenreichii JS7  PFR_JS7-1_251 M.PfrJS7I  ATCNNNNNGTCG  I 
 PFR_JS7-1_659 M.PfrJS7II  CAANNNNNNCTG  I 
 
PFR_JS7-
1_2249 M.PfrJS7III  CGANNNNNNNTTT  I 
 
PFR_JS7-
1_2117 M.PfrJS7IV  CCWGG  II 
 
PFR_JS7-
1_1519 M.PfrJS7V  CTGAAG  II 
P. freudenreichii PJS7 
phage  PFR_JS7-PH_14 M1.PfrJS7aORF14P (not annotated) II 
  PFR_JS7-PH_22 M2.PfrJS7aORF14P (not annotated) II 
P. freudenreichii JS8  PFR_JS8_242 M.PfrJS8I  ATCNNNNNGTCG  I 
  PFR_JS8_2157 M.PfrJS8III  CAGNNNNNNRTCG  I 
 PFR_JS8_2013 M.PfrJS8II  CCWGG  II 
P. freudenreichii JS9  PFR_JS9-1_274 M.PfrJS9I  GCANNNNNNGTGG  I 
 
PFR_JS9-
1_1487 M.PfrJS9II  CAGNNNNNNCTG  I 
 PFR_JS9-1_705 M.PfrJS9III  CTGGAG  II 
  
PFR_JS9-
1_1590 M.PfrJS9IV  ARCCCC    
P. freudenreichii JS10  PFR_JS10_1239 M.PfrJS10I  AGTNNNNNNCTT  I 
P. freudenreichii JS11  PFR_JS11_224 M.PfrJS11I  ACCNNNNNCTTC  I 
 PFR_JS11_2032 M.PfrJS11II  GGANNNNNNNCTC  I 
  PFR_JS11_1917 M.PfrJS11III  CCWGG  II 
P. freudenreichii JS12  PFR_JS12-1_2109 M.PfrJS12I  GCANNNNNNRTGA  I 
 
PFR_JS12-
1_1387 M.PfrJS12III  GGGCCC   II 
   (GGCGGAG )   
   (TANAAG )   
P. freudenreichii pJS12  PFR_JS12-3_27 M.PfrJS12II  CTCGAG  II 
P. freudenreichii JS13  PFR_JS13-1_224 M.PfrJS13I  ACCNNNNNCTTC  I 
 
PFR_JS13-
1_2034 M.PfrJS13II  GGANNNNNNNCTC  I 
  
PFR_JS13-
1_1919 M.PfrJS13III  CCWGG  II 
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Organism  locus Enzyme  Recognition sequence  Type 
P. freudenreichii JS14  PFR_JS14_217 M.PfrJS14I  ATCNNNNNGTCG  I 
  PFR_JS14_1997 M.PfrJS14III  CAGNNNNNNCTG  I 
 PFR_JS14_1883 M.PfrJS14II  CCWGG  II 
P. freudenreichii JS15 
PFR_JS15-
1_281 M.PfrJS15II  CCWGG  II 
 PFR_JS15-
1_2040 M.PfrJS15I  AGCAGY  III 
  
PFR_JS15-
1_303 PfrJS15III  CTTCNAC    
P. freudenreichii JS16  RM25_0134 M.Pfr20271I  GGANNNNNNNCTT  I 
      (TCGWCGA )  II 
P. freudenreichii JS17  PFR_JS17-1_893 M.PfrJS17I*  GAANNNNNNNCTT  I 
  
PFR_JS17-
1_273 M.PfrJS17II  AGCAGY  III 
P. freudenreichii JS18  J18_2127 M.PfrJS18I  CAGNNNNNNCTG  I 
P. freudenreichii JS20  PFR_JS20-1_520 M.PfrJS20I  GACGTC    
 
PFR_JS20-
1_402 M.PfrJS20II  ACGNNNNNNGTGG  I 
  
PFR_JS20-
1_2119 M.PfrJS20III  GCANNNNNNGTGG  I 
P. freudenreichii JS21  PFR_JS21-1_2269 M.PfrJS21I  ACANNNNNNRTAY  I 
  
PFR_JS21-
1_2026 M.PfrJS21II  CCWGG  II 
P. freudenreichii JS22  PFR_JS22-1_2165 M.PfrJS22I**  GAANNNNNNNCTT  I 
 
PFR_JS22-
1_1883 M.PfrJS22II  GRGCYC  II 
 
PFR_JS22-
1_271 M.PfrJS22III  AGCAGY  III 
   (CCGCTC)   
P. freudenreichii JS22 
phage 
PFR_JS22-
PH_50 M.PfrJS22PORF50P (m5C) (not annotated) II 
P. freudenreichii JS23  PFR_JS23_2000 M.PfrJS23I  AGCAGY  III 
  PFR_JS23_1965 PfrJS23II  CTTCNAC    
P. freudenreichii JS25 PFR_JS25-1_2023 M.PfrJS25I ACANNNNNNRTAY I 
*It is possible that that M.PfrJS17ORF2252P is the active methylase in this organism. M.PfrJS17ORF2252P shares 
99% aa sequence identity with M.PfrJS22I, but its corresponding S protein is truncated. 
**It is possible that M.PfrJS22ORF850P is the active methylase in this organism. M.PfrJS22ORF850P is 100% 
identical to M.PfrJS17I. 
 
5.2.4.6 Pilus and mucus binding 
Pili are surface adhesive components and well-documented virulence 
factors for many opportunistic pathogens. However, their role in probiotics 
and/or commensal bacteria as niche-adaptation factors has recently been 
recognised. While the pili of probiotic Bifidobacteria have been reported as 
crucial for establishing host-microbe and microbe-microbe interactions 
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(Turroni et al., 2013; O'Connell Motherway et al., 2011), no pili have been 
reported in Propionibacteria to date.  
A search for pilus clusters using the LOCP tool (Plyusnin et al., 2009) 
identified putative pilus operons in the genomes of JS18, JS20 and JS14, 
consisting of three, four and five open reading frames (ORFs), respectively 
(Figure 26A). The putative pilus operons in JS14 and JS20 were similarly 
organised, and the predicted pilus proteins share 99-94% amino acid identity. 
The ORF prediction and location of functional domains in predicted proteins 
suggested that in the JS14 genome, the genes coding for the putative surface-
anchored fimbrial subunit and the Type-2 fimbrial major subunit were split, 
possibly due to frameshift-causing mutations. A BLASTp search revealed the 
presence of highly conserved gene clusters in all of the P. freudenreichii 
genomes studied here, with a similar structural organisation to the pilus 
operons of JS14 and JS20. The exception was strain JS9, where only partial 
genes coding for surface-anchored fimbrial subunit (PFR_JS9-1_404) and 
sortase (PFR_JS9-1_414) were found with several genes inserted between 
them. In contrast, homology searches revealed that the PFR_J18_2249-
PFR_J18_2248-PFR_J18_2247 operon that was in a genomic island was 
unique for the JS18 strain because no counterpart of the intact operon was 
identified in the other genomes. Per the BLAST searches, the genome of JS9 
carried genes encoding the putative surface-anchored fimbrial subunit 
(PFR_JS9-1_546) and the Type-2 fimbrial major subunit (PFR_JS9-1_547) 
with 100% identity to the gene products of the JS18 genome, but the third gene 
encoding the putative sortase was not present. The predicted pilus proteins 
encoded by the JS18 operon shared 32-54% identity with their counterparts 
encoded by the JS14/JS20 operon, and a BLASTp search against the NCBI 
non-redundant protein database revealed the highest sequence identity (39-
55%) to proteins from Haematomicrobium sanguinis. 
Because in silico searches suggested that the JS18 and JS20 genomes 
carried intact pilus operons, these strains were chosen for electron 
microscopic analyses together with a P. freudenreichii-type strain (JS16) as 
the control. The transmission electron microscopic images of negatively 
stained cells showed that the surfaces of JS18 cells contained pilus-like 
appendages, which were not observed in the JS20 and JS16 cells (Figure 26B). 
Efficient and specific mucus binding is a feature that has not been 
described for Propionibacterium strains. Because mucus-binding is one well-
known function that is mediated by pili in other bacteria (Kankainen et al., 
2009) and because electro microscopy revealed pilus-like structures on the 
JS18 cell surface, specific mucus binding to JS18 was tested and compared to 
the non-specific binding of the control protein, BSA, to JS18. The test revealed 
that the JS18 strain adhered more efficiently to the mucus than to BSA, while 
no specific binding to mucus was observed in the other strains tested (Figure 
26C). The presence of pili and their positive effect on the binding capacity of 
the strain could make JS18 a unique probiotic candidate, and its probiotic 
potential should be explored further.  
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Figure 26 Pili in P. freudenreichii. Panel A: Pili clusters identified by LOCP; Panel B: Transmission electron 
microscopy images of strains JS18 and JS20 carrying the two types of pili operons identified by LOCP, as well as 
JS16 strain used as control; Panel C: The results of mucus binding assay. The binding ability of strain JS18 to 
mucus was significantly higher than non-specific binding to BSA and also significantly higher than the control 
value obtained with PBS and is marked with an asterisk. 
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5.2.4.7 Vitamin B12 biosynthetic pathway 
The vitamin B12 biosynthetic pathway in P. freudenreichii has been 
previously resolved (Falentin et al., 2010; Murooka et al., 2005; Murakami et 
al., 1993; Roessner et al., 2002; Sattler et al., 1995). All of the strains included 
in this study demonstrated an ability to produce active vitamin B12 (Study II), 
and it was confirmed by BLASTp searches that all of the strains possess the 
previously identified B12 biosynthetic genes, with a similar local organisation 
into clusters, and with high level of sequence conservation. Strain JS4 was the 
exception because the hemL and cbiD genes were shorter, and the gene cbiX 
appeared to be missing. However, it was determined that in this strain, a one-
nucleotide-shorter spacer region resulted in a frameshift, which in turn led to 
the formation of a fusion gene of cbiX with the preceding gene cbiH. The visual 
assessment of the raw sequencing data confirmed a deletion of a guanine base 
in the region, which caused the frameshift. Additionally, the predicted sizes of 
cbiX and cbiH had 18- and 15-nucleotide variations between strains, 
respectively, pointing to the variable character of the spacer region. 
The B12 biosynthetic pathway is regulated at the translational level by the 
cobalamin riboswitches (Nahvi et al., 2004). In P. freudenreichii, three of 
these riboswitches have been found upstream of genes cbiL, cbiB and mutA 
(Vitreschak et al., 2003). The B12-riboswitches in P. freudenreichii are not well 
characterised, and the actual span of the element is unknown. However, all the 
elements are expected to possess the conserved B12 binding region, termed the 
B12-box, which is characterised by a consensus sequence, 
rAGYCMGgAgaCCkGCcd (Vitreschak et al., 2003). Based on previous reports 
(Nahvi et al., 2004; Vitreschak et al., 2003), the predicted sequences for the 
three putative riboswitches were retrieved and compared among the strains. 
All of the tested P. freudenreichii strains possessed the expected three 
riboswitches, which were highly conserved between the strains, with the B12-
box consensus for the species, SAGYCMSAMRMBCYGCCD. It may be 
significant that the riboswitches of the cbiL and mutA genes are located very 
close to each other and in opposite orientations, but the implications of this 
positioning remain unclear. 
Conclusions 
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 CONCLUSIONS  
The results presented in this study confirm that P. freudenreichii is capable 
of synthesising endogenous DMBI from reduced FMN, as long as oxygen is 
available during fermentation. Under strictly anaerobic conditions, no 
production of active vitamin occurs, which was attributed to the inability to 
form DMBI by the oxygen-dependent BluB domain of the BluB/CobT2 fusion 
enzyme. 
The yields of vitamin B12 produced by the strains that were grown in 
supplemented WBM medium were strain-dependent. All of the P. 
freudenreichii strains produced active vitamin B12 under all conditions tested, 
while A. acidipropionici produced small amounts of vitamin only when DMBI 
was supplied. The overall high yields in the P. freudenreichii strains were 
attributed to the addition of cobalt and the consumption of high amounts of 
riboflavin naturally present in the medium. Supplementation with DMBI or 
nicotinamide had an additional positive effect on vitamin B12 yields but only in 
some of the strains. These results suggest that P. freudenreichii does not 
require DMBI supplementation under the conditions tested. 
Finally, it was showed that when grown in two media with different effects 
on cell metabolism, P. freudenreichii 2067 produced nutritionally relevant 
amounts of active vitamin B12 without the need for cobalt or DMBI 
supplementation. P. freudenreichii is a food-grade bacterium, and the results 
confirm that it can be used for in situ fortification of foods in vitamin B12, where 
addition of neither DMBI nor cobalt is allowed. 
Genome sequencing did not reveal a clear genetic background for the 
differences in the levels of vitamin B12 production between the tested strains, 
but the availability of the genomic data will facilitate future studies. However, 
the whole genome sequencing from the long reads enabled the discovery of 
previously unknown characteristics of the species. Among them, the potential 
transposase-mediated adaptation strategies reflected by the differences in 
genome organisation between closely related strains was described; two 
putative-plasmid structures were identified, and for the first time, the 
complete prophages that integrated into the bacterial chromosomes and were 
also observed in their free, circular forms were reported. Moreover, the 
systems that protected P. freudenreichii from invading DNA, namely, the 
CRISPR-Cas and the RM systems were analysed using bioinformatics tools. 
Both types of the defense systems have been observed in P. freudenreichii 
before, but their classification, diversity and distribution was described for the 
first time in current work.  
Finally, an unprecedented complete pilus structure formed by the P. 
freudenreichii JS18 strain was identified and then associated with the specific 
mucus binding. Taken together, the results reported here improve the genomic 
characterisation of P. freudenreichii and provide a foundation for further, 
more in-depth studies of the species. 
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